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Studies in Theoretical Biology: 
A Collection of Undergraduate Research 
Carlos Castillo- Chavez 
Abstract. In this introductory note, we describe the research from the work of thirty-five 
undergraduates and a high school student. who participated in an intensive forty-five day 
program: the Cornell-SACNAS Mathematical Sciences Summer Institute (CU-SMSSI). 
Cornell-SMSSI is a program embedded in Cornell's Mathematical and Theoretical Biol-
ogy Institute (MTBI) which is devoted to providing research opportunities to undergrad-
uate college students across the nation, with the encouragement of the Society for the 
Advancement of Chicanos and Native Americans in Science. MTBI through the estab-
lishment of culturally sensitive environments, facilitates and instigates the active partic-
ipation in the scientific enterprise of minority undergraduates. CU-SMSSI's environment 
was designed to meet the cultural needs of Chicanos, Latinos, and Native Americans 
(SACNAS). CU-SMSSI students learned about dynamical systems and probability mod-
els through the study of their applications to ecology, evolutionary biology, epidemiology 
and immunology during the first four weeks of the program. The last two-and-a-half weeks 
were devoted to the development of mathematical models from the students' efforts to 
answer specific scientific questions. The research of six interdisciplinary groups was-in 
part-motivated by recent theoretical advances in the fields of theoretical/mathematical 
epidemiology, immunology, ecology, demography, and sociology. The papers described in 
this note are part of the Biometrics Unit Technical Report Series. If a request for this 
note is made, it will send along with the six student reports. 
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1. Introduction: 
CU-SACNAS Mathematical Sciences 
Summer Institute. 
The main objective of the Cornell-SACNAS Mathematical Sciences Summer lnsti- , 
tute (CU-SMSSI) is to provide a first rate research experience in theoretical and 
mathematical biology to Chicano, Latino, and Native American students through 
a summer training program that includes participation in a series of small group 
research projects. CU-SMSSI's research training program in theoretical and mathe-
matical biology is part of Cornell's Mathematical and Theoretical Biology Institute 
(MTBI) for undergraduate research. Cornell University's top-ranked programs in 
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biometry, statistics, ecology and evolutionary biology, applied mathematics, math-
ematics, and computer science and its NSF-supported supercomputing facility pro-
vide an ideal environment for MTBI. CU-SMSSJ's research training program has 
been designed to provide an interdisciplinary research experience for undergradu-
ates in mathematics, biology, and related disciplines who have completed at least 
a year of calculus. The research outlined in this report was completed by students 
who had mostly completed two years of college (albeit we had a student who had 
completed only his freshman year as well as a high school student). The program 
seeks students majoring in mathematics, biology, or related fields who have had a 
year of calculus and who are at least two years away from completing their college 
degree. 
CU-SMSSI students learned about dynamical systems and probability models 
through the study of applications to ecology, evolutionary biology, epidemiology, 
and immunology during the first four weeks of the program. The last two-and-
a-half weeks were devoted to the development of mathematical models from the 
students' efforts to answer specific scientific questions. The research of six interdis-
ciplinary groups was-in part-motivated by recent theoretical advances in the fields 
of theoretical/mathematical epidemiology, immunology, ecology, demography, and 
sociology. The papers described in this brief note are part of the Biometrics Unit 
Technical Report Series. 
Research topics given to the students emphasized questions associated with 
the evolution of virulence, coexistence of species, population dynamics of tropical 
diseases, immunology of tuberculosis, the dynamics of communicable diseases, the 
spatial spread of diseases, and the dynamics of sexually-transmitted diseases. The 
last two-and-a-half weeks were mostly dedicated to the research projects. Research 
was conducted in groups of six students (not all with the same college major) and 
focused on problems at the interface of biology and mathematics. Each of the six 
groups was required to write up a research technical report, as well as to present 
their findings to the group in a final series of presentations. 
2. Research Projects 
Biological questions can be studied at different spatial, temporal, or organizational 
scales. Two issues relevant to the the students research are: (i) how much orga-
nizational detail such as age structure, immune response, or genetic variability 
must be included in biological models? and (ii) how do we model relevant detail? 
In fact, by selecting a particular level of organization (immune system level or 
the population level) and a particular model, the investigator may have decided 
a priori what is and what is not relevant. This problem, although often discussed 
in the biological and social sciences, is not seriously.a~dressed in the epidemiolog-
ical/immunological literature. · · 
The social consequences of epidemics such as the HIV /AIDS epidemic, the cur-
rent rise of tuberculosis and the emergence of new diseases such as ebola provided 
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strong motivation to the students who could relate to the main culprit behind dis-
ease dynamics, poverty. The issue of scale resulted from students efforts to decide 
what question to address. Students interested in tuberculosis (TB) had to decide 
whether or not to study the dynamics of TB at the individual (immune s:vstem) or 
at the population level. Students interested in ebola were concerned with under-
standing outbreaks and estimating the basic reproductive number of ebola through 
the use of existing outbreak data. Students interested in H1V decided to focus on 
models that would help them estimate the life spans of free virions and infected T 
cells of H1V-infected patients. Another group was interested in the role of hetero-
geneity (core group dynamics) on the dynamics of sexually-transmitted diseases. 
Another group studied the dynamics of a tick population affected by Rocky Moun-
tain Spotted Fever in order to rmderstand how this disease affects other species. 
Finally, a group focussed on the study of the effects of spatial heterogeneity on 
disease dynamics. Hence, we had students looking at disease dynamics at various 
levels of aggregation as well as at different temporal and spatial scales. 
Christian Herrera, Sharon K. Lima, Roberto Munoz, Gloria Ramos, Ariel 
Rodriguez and Claudia Salzberg focus on a mathematical model that describe 
the dynamics of the immrme system in the presence of the causative agent of 
tuberculosis, Mycobacterium tuberculosis. Their model takes into consideration 
the relations between the bacteria, T lymphocytes, and macrophages. The basic 
reproductive number is computed in order to determine rmder which conditions the 
immrme system experiences no infection, latency, and active infection. The model 
can exhibit the dynamics of these three conditions of the disease for appropriate 
regions of parameter space. Two types of treatment are considered and the students 
analyze their effect on the dynamics of the system. 
Jaime Astacio, Delmar Briere, Milton Guillen, Josue Martinez, Francisco 
Rodriguez, and Noe Valenzuela-Campos use S-1-R and S-E-1-R models to simulate 
and fit the data of two ebola outbreaks: the 1976 outbreak in Yambuku, Zaire and 
the 1995 outbreak in Kikwit, Zaire. The basic reproductive number, R.J, determines 
the likelihood and magnitude of an outbreak. Using available data, this group was 
able to estimate the basic reproductive number for ebola. They found it to be in 
the range 1. 72E.J5.32. 
Judit Camacho, Fernando Carre6n, Derik Castillo-Guajardo, Hugo Jimnez-
Perez, Leticia Montoya-Gallardo, and Ricardo A. Saenz consider a special case 
of the general spatial SIR (susceptible-infectious-removed) model. It is assumed 
that the population is distributed in separate cells and that there is no migration 
of individuals between cells. It is also assumed that disease can be transmitted 
with some probability within the cell by direct contact between an infected and 
a susceptible individual, but from cell to cell only through an external object 
capable of carrying the disease agent. The model was simulated in a lOxlO grid 
of cells, and it was assumed that the disease can only be transmitted (via some 
external object) from a cell with infected individual to its immediate neighbors 
with some probability. The simulations showed typical spatial wave dynamics and 
dependance on initial conditions. 
;I 
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Michelle Arias, Erika Camacho, Rafael Castillo, Delmy Iniguez, Eliel Melon, 
and Luz Parra begin with the observation that antiviral drugs may prolong the 
lives of HIV-infected patients although it is still uncertain if these drugs affect 
the rates of virion clearance, the loss of target cells, or both. A mathematical 
model was derived and applied to data to calculate the life spans of free virions 
and infected T cells. It was found that the antiviral drug decreased not only the 
number of free virions in the plasma but also the loss of infected target cells. 
Marina Bobadilla, Sharon Lozano, Jessica Maia, Julio Villareal, Novaline Wil-
son and Roberta Winston (1996) examine a mathematical model for the dynamics 
of sexually-transmitted diseases where a vaccine (or an education program) capa-
ble of providing permanent protection (or permanent change in behavior) when 
effective is introduced into an infected population of highly-active individuals (the 
core group). The prevalence of the disease within the core group determines the 
recruitment rate into the core group. Oscillations of the disease over time were 
observed. 
Mary Alderete, Carlos Castillo-Garsow, Guarionex Jordan Salivia, Carlos Lara-
Moreno, Gina Ramirez, and Monica Yichoy study the dynamics of the tick popu-
lation affected by Rocky Mountain Spotted Fever in order to understand how this 
disease affects other species. The model proposed by Busenberg and Cooke !1993] 
for the tick population dynamics was modified to account for additional biological 
aspects. Numerical simulations are conducted to assess the effect of parameters on 
the dynamics of the model. It is observed that there is a region of parameter space 
where the population's behavior is found to be chaotic, and the boundaries for 
which chaos arises are computed numerically. It appears that additional biological 
detail affects the shape and location of the attractor. 
3. Conclusions 
I have edited the students' reports and this note tries to put their researh find-
ings into a broader scientific context. It was tempting but impractical to encourage 
further development of research results, as it is difficult to mantaing good commu-
nication among group members, and undergraduate students are usually terribly 
busy during the academic year. Furthermore, I thought that it was important to see 
the truly impressive accomplishments of a diverse group of students who learned 
the basics of modeling, dynamical systems, probability, and stochastic processes 
while developing additional computational skills in four weeks. These four weeks 
of preparation were then followed by intense immersion in the biological literature 
needed to address their chosen biological questions, build a model, and carry out 
some preliminary analysis. 
The titles of the six technical reports written by the students are listed in the 
references. 
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ABSTRACT 
We present a mathematical model to describe the dynamics of the immune 
system in the presence of the causative agent of tuberculosis, Mycobacterium 
tuberculosis. We take into consideration the relations between the bacteria, 
T lamphocytes, and macrophages. We compute the basic reproductive num-
ber to determine under which conditions we get certain disease states: no 
infection, latency, and infection. The behavior depicted by our model, under 
certain parameters, demonstrates the dynamics .of these three conditions of 
the disease. We consider a treatment and analyze its effect on the dynamics 
of the system. 
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1 Introduction 
During the 1800s, tuberculosis was an epidemic disease throughout the world. 
Due to improvements in living conditions and advances in medicine, the in-
cidence of tuberculosis began to decline in the 1900s. However, it has re-
mained a major cause of death in developing countries. It is transmitted 
through coughs and sneezes by a person with infectious (active) tubercu-
losis. Healthy persons who are infected have a high probability of being 
asymptomatic. There is a 10% risk of developing active tuberculosis after 
being infected [Hopewell 1994 J. When tuberculosis is latent, it is incapable 
of being transmitted and does not cause any symptoms [Miller 1993]. 
Currently the number of cases of tuberculosis again is on the rise. Ap-
proximately one third of the global population is infected by Mycobacterium 
tuberculosis [Sudre et al. 1992], the causative agent of the disease. This 
makes tuberculosis one of the most common infectious diseases in the world. 
Some of the factors that have caused this increase of the disease are: immi-
gration, overcrowded living conditions, substance abuse, and AIDS. Newly 
evolved strains that are resistant to one or more drugs used in treatment 
have developed with this new resurgence of tuberculosis. 
An increase in awareness has motivated basic research on the pathogenesis 
of the bacteria and the mechanisms of the immune response. Our research 
is based on the microbiological perspective of tuberculosis and the immune 
system. The focus is on the immune system-pathogen interaction. Work 
using this approach has been done with Chagas' disease [Velasco-Hernandez 
and Perez-Chavela 1992] and the HIV virus. 
In tuberculosis, the interaction among the causative agent, the macrophages, 
and the T cell (CD4/CD8) populations establishes the state of the disease. 
The interaction between the bacteria and the immune system can be viewed 
as the combination of two ecological processes: predator-prey and pathogen-
host interaction. Using this blended model, we analyze the potential out-
comes resulting from human exposure to Mycobacterium tuberculosis. Three 
outcomes will be examined: no infection, a latent state of infection, and an 
infectious (active) state. The present paper seeks to model the dynamics 
between the Mycobacterium tuberculosis and the cells of the immune system 
by considering five separate populations: Mycobacterium tuberculosis, empty 
macrophages, inactivated macrophages, activated macrophages, and T cells. 
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We seek to determine which initial states and which parameters lead to dif-
ferent outcomes in the health of the infected individual. From these findings 
we will have a better understanding of the immune system and its response 
to Mycobacterium tuberculosis. This may enable scientists to foresee and 
prevent the death of an infected individual. 
2 Mathematical Model 
A realistic model of the interactions between the immune system and My-
cobacterium tuberculosis is required to elucidate the dynamics of these in-
teractions. A notable limitation in the construction of this model has been 
the lack of understanding the mechanisms involving the immune response to 
Mycobacterium tuberculosis. To account for these limitations it is necessary 
to make some assumptions about the process and incorporate them into our 
model. There is still an ongoing debate as to the importance of the role of 
the humoral response, but in order to simplify the model we have assumed 
that it is negligible and have concentrated exclusively on the cell-mediated 
response. 
The cell-mediated immune response includes the action of macrophages, 
or phagocytic cells able to digest foreign material, and T cells which facilitate 
the activation of the response by secreting growth and cell-activating factors. 
The model discussed here includes effects of CD4+ and CD8+ T cells. We 
do not distinguish between these two subpopulations. More explicitly, we 
have taken the liberty to consider their total effects as additive. Therefore 
we focused on a broader concept of a T cell which combines the outcomes of 
both these subpopulations. 
A very important note to consider is that our model presumes infection 
and concentrates on the possible outcomes of this infection. We consider 
infection only in the primary infection site. We do not consider spread of the 
bacteria via travel of the alveolar macrophages into other parts of the body 
nor do we consider systemic infection. We have considered three general out-
comes which are summarized in Figure 1. All outcomes presume engulfment 
of bacilli by the alveolar macrophage. Once in the macrophage, the bacilli 
can restrain their growth and remain unnnoticed for years. The length of 
time which these bacilli can remain unnoticed inside macrophages depends 
on the individual. Genetic patterns have been observed with respect to the 
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length of this latent state (Rossman & Macgregor 1995). If the bacilli repli-
cate once inside the macrophage, the stress of this activity will lead to an 
immune response involving the T cells. From the latent state we can have 
reactivation of bacterial replication which will lead to a similar response. The 
mechanisms which activate this replication in latent-state bacilli remain un-
clear. Once an immune response is mounted we have two possible outcomes: 
defeat of the bacilli due to their destruction and elimination, and uncon-
trolled infection whereby the immune response was not strong enough to 
eliminate the pathogen, leading to symptomatic tuberculosis. Thus we con-
sider the outcomes of infection as latency, infection progression, or infection 
elimination. 
2.1 Macrophage growth and infection 
In order to consider the relation of the macrophages to the system we have 
to consider the roles they play in the immune response mounted against the 
bacteria. We consider three states of the cell. The first is the free state 
before its encounter with a bacilli (M). In this state it simply remains 
prepared for an encounter with a foreign antigen. The next state is the 
inactive state from chance encounters with a tuberculosis bacilli (M*). In 
the inactive state it now contains the bacilli within its cytoplasm (i.e., it is 
now full) yet remains inactivated. The third state consists of the activated 
full macrophage ( M**). Activation occurs from chance encounters of a T cell 
which, after recognizing it, begins to mount an attack partly by activating the 
macrophage. The actual process of activation is also unclear, although there 
are some hypotheses, including the belief that when the T cell activates the 
macrophage it enables it to produce nitrogenous compounds which the bacilli 
cannot resist. As a model for these three states we suggest the following: 
dM/dt 
dM* jdt 
d}.f** jdt 
fJ- oM- EMP, 
EMP- aTM*- (o + g)M*, 
o:T M*- oM**, 
(1) 
(2) 
(3) 
where (J represents the birth rate of macrophages as seen in the bone mar-
row of a healthy adult; o the natural cell death rate; E the engulfing rate 
of a macrophage with respect to a bacillus; a the activation rate of a full 
macrophage with respect to its encounter with a T cell; and g the rate of 
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bursting of a macrophage as a result of the unbounded proliferation of bacilli 
inside its cytoplasm. 
We have left out the possibility of a varying birth rate, although taking 
this possibility into account would make our model more realistic, since there 
is an increase in macrophages when a full one meets up with aT cell. 
2.2 T cell proliferation 
Immune response depends on chance encounters ofT cells with M* macrophages. 
The T cell recognizes the M* macrophage and begins mounting an attack 
that not only activates the macrophage but also allows for the secretion of 
substances such as INF')' (which kills free bacteria as well as destroys sur-
rounding tissues). The T cells also self-replicate in the process. Thus we 
consider the following equation to model the dynamics of the T cells: 
dT / dt = A + rT M* - brT. (4) 
where A is the birth rate for the formation of the T lymphocyte in the bone 
marrow of a healthy adult; br is the natural cell death rate of the T cell; and 
r is the rate of replication of the T cell upon encountering a full macrophage. 
We have assumed that the birth rate is constant but we are aware that it 
should be represented as a function of T. 
2.3 M. tuberculosis growth in an infected individual 
The causative agent of tuberculosis is transmitted via the inhalation of in-
fectious droplets emitted during an infected person's coughing, sneezing, or 
spitting. The contraction of the disease by a susceptible guinea pig or rabbit 
depends on the inhalation of droplets limited to the size of 1 to 3 bacilli in 
order to facilitate their engulfment by macrophages. Equivalent data is not 
found on humans so we have assumed a similar pattern of dependence in 
modeling the immune response for humans. As a model we propose: 
dP/dt = bP- bpP- EMP + (bN + gL)M*, (5) 
where Pis the number of bacilli as would be measured in the blood; bp the 
natural cell death rate; N the number of bacilli inside a macrophage when 
it dies a natural cell death; and L the number of bacilli required in order to 
burst a macrophage. 
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3 Analysis and Simulations 
3.1 Analysis 
Our model consists of the following set of differential equations: 
dMjdt f3- t5M- EMP (6) 
dM* jdt EMP- aTM*- (8 + g)M* (7) 
dM** jdt o:T M*- t5M** (8) 
dTfdt A +rTM*- 8TT (9) 
dP/dt bP- 8pP- EMP + (t5N + gL)M*. (10) 
To begin the analysis of the system we compute the steady states for (6)-
(10). For the disease-free equilibrium we take P = 0, M* = 0, and M** = 0, 
since in the absence of bacteria we would have no engulfing, hence no M* 
nor M** cells. From (1) and (4) we have 
0 = (3- 8A1 and 0 =A- 8TT 
so 
E0 = (M0 ,M;,M;*,T0 ,Po) = ((3j8,0,0,A/8T,O). 
The Jacobian matrix of the system at Eo is 
-8 0 0 0 -tf!. 
-(8+g+a~) c 0 0 0 tf!. 6 
JEo = 0 Q~ -8 0 0 Cr 
0 0 0 -8 0 
0 8N+gL 0 0 b-{5 -Ef!. p c 
Let 
C=(-(8+g+a~) t~ f3)· 
8N + gL b- 8P - e6 
For the stability of E0 , we can see that the real part of all eigenvalues of the 
matrix JEo is negative if and only if both 
det(C) = (aA/8T + 8 + g)(E(3jt5 + 8p- b)- (8N + gL)(E/3/8) > 0, 
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and 
tr(C) = -(o.AI8T + 8 +g)- (EfJI8 + 8p(b) < 0. 
The condition in the determinant is equivalent to 
(EfJI8)(8N + gL) 
(EfJI8 + 8p- b)(o.AI8T + 8 +g) < 1. 
We define the basic reproductive number as 
(EfJI8)(8N + gL) 
(E{Jjb + Dp- b)(aAI8T + 8 +g). 
This parameter relates the average number of engulfings per lifetime of M 
( E/3 I 8) per "true" lifetime of bacteria ( E/3 I 8 + 8p- b) with the average number 
of released bacteria (8N +gL) per "true" lifetime of M* cells (o.AI8T+8+g). 
Ro reflects the interplay of epidemiological, predator-prey, and population 
growth factors in our model. It relates epidemiological factors for the M ~ 
M* ~ M** dynamics, predator-prey interactions between the M and P 
population, and the population dynamics of P. 
For Ro to make sense we should have E/3/8 + bp- b > 0. If we consider 
the case when E/318 + bp- b < 0, then bacteria will increase exponentially. 
To see why this happens, from (1) we can see that M < !318. From (5) we 
have 
dPjdt ~ (b- 8p- E/3 lb)P; 
thus 
P(t) ~ P(O)e<b-op-f/3/o)t ~ oo as t ~ oo. 
To determine endemic equilibria, we set equations (1) - (5) equal to zero. 
From (4) and (5) , 
T = A8T- rM* for M* < 8Tir and p = (bN + gL)MP* bp +EM- b . 
Substituting these equations in (1) and (2), we have 
0 = f3- 8M- EM(bN + gL)M* 
bp +EM- b 
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and 
0 =eM (oN+ gL)M* A M* (£ )M* 
... - a£ M* - u + g . Op + EM - b ur - r 
Adding these two equations and solving for M gives us 
1 [ aAM* ·] M = 8 {3- or- rM•- (o + g)M . 
Let x = M*, then let g1(x) =or- rx, g2(x) = [{3- 6 + g)x]gi(x)- aAx. 
Then M can be expressed as 
M = g2(x) with x = M*. 
6g1 (x) 
Substituting M in the second equation from (*) and considering M* > 0 we 
define 
Take 
F(x) = E(oN + gL)g2(x) _ (o +g)= O. 
(op- b)og1(x) + Eg2(x) 
E(oN + gL)g2(x) 
e1 (x) = (op- b)6g1(x) + Eg2(x)' 
a A 
e2(x) = -(-) + (6 +g). gl X 
Solving for x ( = M*) would be finding x such that these two curves intersect: 
e1(x)- e2 (x) = 0. 
We show the existence of such an x, hence the existence of endemic 
equilibria. We restrict the analysis to the interval [0, oyjr). Note that 
F(O) = e2 (0)(~-1). For~> 1 wehaveF(O) > 0. NowconsiderX* = 6r/r. 
Note that 
lim e1(x) =oN+ gL, and lim e2(x) = oo. 
X->X* X->X* 
Then 
lim F(x) = -oo. 
X->X* 
Since F(O) > 0 and for some h, F(6r/r- h) < 0, then F(c) = 0 for some 
c E (0, 6r/r). This shows the existence of an endemic equilibrium. We now 
show that for Op 2:: b the endemic equilibrium is unique. Computing F'(x), 
aAr 
F'(x) = &(b- op)(oN + gL)[(o + g)g~ + o:Ag1 + ro:Ax]- - 2 , gi 
we can see that for Op 2:: b, F'(x) is strictly negative. This shows that there 
is only one c E (0, 6r/r) such that F(c) = 0, when Ro > 1. 
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3.2 Simulations 
We complete our analysis through computer simulations. In the previous 
section, we determined analytically the conditions for stability of the disease-
free equilibrium, the existence of endemic equilibria for Ro > 1, and the 
uniqueness of an endemic equilibrium for the case where b p ~ b, with Ro > 1. 
Through the simulations we corroborated our analytical results and ex-
tended them. The main purpose of the simulations was to find the three 
possible stages of tuberculosis: active, latent, and no TB. We identified the 
active stage with an exponential growth of the bacteria, the latent stage 
with an endemic equilibria, and the no-TB stage with the disappearance of 
bacteria. 
While doing the simulations, we considered the cases where Ro < 1 and 
Ro > 1. This was done because of the lack of information on most of the 
parameters. We define 
Rl = Ej3jb bN + gL a;£ £ b and R2 = Ajb b . EfJ U + Up - (} T + + 9 
For each of the cases, we considered three sub-cases, each a different 
combination of values for R1 and R2 • For Ro < 1 we considered: 1) R1 < 1, 
R2 < 1; 2) R1 > 1, R2 < 1; 3) R1 < 1, R2 > 1. For Ro > 1 we considered 
the cases: 1) R1 > 1, R2 > 1; 2) R1 > 1, R2 < 1; 3) R1 < 1, R2 > 1. In each 
of these cases we paid most attention to the behavior of P( t) (bacteria) and 
M ( t) ( macrophages). 
We obtained no TB (P(t) -t 0, M(t) -t /3/b) in the cases where Ro < 1 
and R 1 < 1. This can be interpreted as follows: R1 < 1 is true only if b p > b. 
Since bacteria is dying at a higher rate than their birth we would expect a 
settled growth of bacteria. With Ro < 1 this behavior settles to the disease-
free equilibrium. 
Our model showed latency (P(t) -t kr, M(t) --+ k2) in the case where 
Ro > 1, with R1 < 1 and R2 > 1. R1 < 1 means bp > b, and R2 > 1 means 
that there is a higher "release" rate of bacteria with respect to the removal 
of A1* cells through activation. A latent stage is expected with high release 
rate and high death rate for bacteria since it is plausible to get a "balanced" 
system. 
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We found active TB (P(t) -t oo, M(t) -t 0) in the case where Ro > 1, 
R 1 > 1 and R2 > 1. This can be interpreted as the consequence of b > b p 
(R1 > 1) and a high release rate (R2 > 1). 
We also obtained interesting results for the cases where R1 > 1 and 
R2 < 1, both with Ro < 1 and Ro > 1. For some initial conditions, as the 
ratio Rd R2 increased we could observe a transition from a disease-free state 
to an active stage of exponential growth for P(t). This was obtained for 
Ro > 1 and Ro < 1. The transition was sensitive to initial conditions. We 
do not give a biological interpretation because of the complex behavior. See 
Appendix for graphs. 
3.3 Treatment 
It is interesting to note the possible effect of treatment on the dynamics of 
the system. We consider a drug with an intracellular and an extracellular 
effect. Equations (2) and (5) would be modified in the following way: 
dM* fdt = EMP- aTM*- (b + g)M*- ¢M*, 
and 
dP/dt = (b- bp )P- EM p + (bN + gL)M*- ¢P. 
The corresponding basic reproductive number is 
(E(Jj6)(6N + gL) 
Ro(¢) = (E(J/6 + 6p- b + ¢)(aA/br + 6 +g)¢)· 
From Ro ( ¢) we can note that the effect of treatment is an expansion of 
the domain of parameters that stay within the conditionRo < 1, with R 1 < 1 
and R2 < 1. 
4 Discussion 
Our paper we proposes a system of differential equations to describe what 
happens when tuberculosis is in an infected individual. We found in our 
solution analysis the three possible results of TB after it attacks the body: 
latent or inactive TB, active TB, or a full recovery from the infection. 
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Our first important step in the analysis of our model was obtaining Ro, 
the basic reproductive number, which gave us the conditions of the three 
possible outcomes of TB when it attacks the individual. We also were able 
to find the stability condition in the disease-free state. In addition, we were 
able to prove the existence of an endemic state when Ro > 1. In particular, 
if 8b > b then we are guaranteed uniqueness of this endemic equilibrium with 
Ro > 1. 
In our analysis, we saw the importance of the engulfing mechanism. The 
macrophages served as a "reservoir" for the Mycobacterium tuberculosis. Ei-
ther the bacteria are released into the immune system by explosion or the 
macrophages annihilate the bacteria. Through computer simulations, we 
were able to identify the important factors of the system that gave us dif-
ferent outcomes. These factors are: the birth of the bacteria, the death of 
the bacteria, the engulfment rate of the bacteria by the macrophages, the 
release of the bacteria by the macrophages, and the activation rate of the 
macrophages by the T-cells. Another important result was the interesting 
outcomes during the latent state of the disease. Latency was either perma-
nent, temporary, or the person made a full recovery from the disease. From 
our system of differential equations, we found the three outcomes that we 
wanted to find, depending on the value of Ro , R 1 ,and R2 . 
However, our model did behave strangely; some of the analytical inter-
pretations did not coincide with the computer analysis. There are special 
conditions in the model, such as a "gray area" where a slight change in the 
value of certain parameters changes the state of tuberculosis. A plausible 
explanation for the unusual behavior in the model is that many of the pa-
rameters in the model have not been found. For example, the engulfing rate . 
of the bacteria is questionable. Also, we do not know the duration of the 
hibernation period of the bacteria in the macrophage. The lack of biological 
parameters limited our interpretation of our mathematical model. 
The immunological model was further extended to include an intracellular 
and an extracellular treatment. This new parameter would be subtracted 
from the P and M* equation. This would affect the Ro because the new term 
would appear in the denominator of the basic reproductive number. Time 
did not permit us to do a complete analysis but from our interpretation of 
the model, we see that the likelihood of proper treatment raised the chances 
to a full recovery. 
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A possible area for further research is to extend the model to include 
another factor that is causing a weak immune system, such as HIV. Anyone 
infected with HIV is more likely to die of tuberculosis because HIV weakens 
the system, often allowing the tuberculosis to take over the immune system. 
Studies have shown that certain groups are more likely to become infected 
with tuberculosis than others, such as substance abusers, smokers, and the 
poor. We could accommodate the model to become specific to high-risk 
groups. We may be able to find similar patterns between each of these 
groups and be able to easily identify others who will fall in the defined high-
risk group. Can a target treatment be designed for these high-risk groups? 
What happens if we consider resistant strains? We hope this project will 
lead others to study these important questions concerning the disease. 
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6. Appendix 
Figure 1 
Visible dynamics of Tuberculosis and the Immune System 
Swallowed by Macrophage (alveolar nonactivated) 
Ro< 1: 
1 6 
Figure 2 
B, M 
M 
B, M 
B, M 
B, M 
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Ro> 1 
Figure 3 
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Rt > 1, R2 < 1 
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Figure 4 
R2 
1 
0 1 
Outcomes after exposure: 1 -No TB, 2- Latent TB, 3 -Active TB, depending on the 
values of parameters R1 and R2• The region under the curve is when Ro < 1; over the 
curve we have Ro > 1. 
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ABSTRACT 
Using S-I-R and S-E-I-R models, it was possible to simulate two Ebola out-
breaks: the 1976 outbreak in Yambuku, Zaire and the 1995 outbreak in Kik-
wit, Zaire. The dynamics of these models are determined by the per-capita 
death rate of infected individuals and the per-capita effective contact rate 
of an individual contracting the disease. The basic reproductive number, 'R, 
determines the infectiousness of the disease. For Ebola, 1.72 ~ 'Ro ~ 8.60, 
and this implies that Ebola is not as infectious as previously postulated. The 
results of these outbreak simulations will equip scientists in future outbreaks 
with information that may enable them to minimize potential deaths. 
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Introduction 
The origin of the Ebola virus is somewhat obscure. There have been 
only three major known outbreaks of the Ebola virus, and all have happened 
in West Central African countries. The latest major outbreak occurred in 
Kikwit, Zaire in 1995. The outbreak took the lives of 79 people. 
Ebola is a unique member of the ribonucleic acid virus family that has no 
known natural reservoir. The incubation period of Ebola is 2-21 days, and 
the infectious period is 4-10 days. The onset of Ebola is characterized by 
severe headaches, malaise, fever, vomiting, bloody diarrhea, and rash. Severe 
bleeding and shock are usually followed by death. Diagnosis of Ebola can be 
difficult, because Ebola is frequently misdiagnosed as typhoid and malaria. 
Currently there is no treatment of Ebola [3]. The mortality rate of Ebola is 
anywhere from 50-90%. Ebola is transmitted through primary contact with 
health workers who are in direct contact with body fluids from the infected. 
Ebola can also be transmitted through secondary contact by family members 
caring for the infected. Finally, Ebola can be transmitted where infection 
control mechanisms are not in practice. These control mechanisms can be 
as simple as wearing gloves, or as complicated as level-four disease control. 
Airborne spread has not been proven as a means of transmission. 
Our objective is to better understand the mathematical dynamics of a 
population infected by Ebola when an outbreak occurs. To model this out-
break, we are using systems of differential equations. Several distinct models 
will be used to study the known data; each model differs in the way the pa-
rameters are acquired. From these different models we will choose the model 
that best fits the data. 
Inaccuracies in the model are to be expected since the parameters dic-
tating the behavior of the model are obtained from only a few data points. 
There have been so few major outbreaks that the amount of data available 
is limited. The model's precision is dependent on this limitation. 
1. Ebola outbreak of 1995 in Kikwit, Zaire. 
The object of this part of the project is to model Zaire's 1995 Ebola epi-
demic, using the Susceptible-Infectious-Recovery (SIR) model (Brauer and 
Castilla-Chavez, 1994). The dynamics of this system happen in two stages: 
susceptible to infected, and infected to dead. This is a closed system where 
those that are susceptible could become infected at some point in time. This 
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model assumes that the initial population is equal to the population that 
will eventually be infected. The parameters are JL, the per-capita death rate; 
and /3, the probability that a susceptible host will become infected. The 
parameter f3 can vary from a constant function to an exponential function 
of decay with respect to the number of infected at timet. Once the param-
eters are found, the system modeling the data is solved using Mathematica 
2.22. Mathematica uses the Runge-Kutta method to solve these differential 
equations. 
The population studied is divided into three Classes: S(t), the number of 
susceptible individuals; I(t), the number of individuals infected; and R(t), 
the number of dead individuals at timet. We will assume that the population 
studied will be a constant population during the outbreak, meaning there are 
no deaths due to outside factors and the number of births that occurred are 
so small that we can essentially ignore them. (This is a valid assumption 
since the lengths of the Ebola epidemics are not longer than three to four 
months.) We will denote our total population at timet by N, so at any time 
t, N = S(t) + I(t) + R(t). 
Following a model proposed by Kermack and MacKendrik (1927) to ex-
plain the frequent rapid rise and fall of cases observed frequently in epidemics 
such as the Great Plague in London (1665-1666), the cholera epidemic in Lon-
don (1865) and the plague in Bombay (1906), we are able to propose a model 
that approximates the outbreak reasonably well: 
dS 
-f3SljN, dt -
dl (JSI /N- Jll, dt -
dR p.J. -dt 
This model takes into consideration the number of people infected due to 
direct contact with an infected individual at timet: f3SI/N, where f3 = pc; 
pis the probability of successfully getting infected when coming into contact 
with an infected individual, and c is the per-capita contact rate. The death 
rate is denoted by f.ll, where J1 is the per-capita death rate. Even though 
recoveries do occur, we will not return these individuals to the susceptible 
class since there has never been a person who has recovered from Ebola and 
contracted the disease again in the same epidemic. 
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The data which we are studying is of the number of people that died each 
day during the outbreak in Kikwit, Zaire in 1995 [4]. See Figures 1 and 2. 
The second data set is the total number of dead individuals at time t, which 
can also be interpreted as the integral of the daily death data. From this 
relation we will be able to estimate the parameter /3 by solving the second 
differential equation for small values of t and relating it to the number of 
dead at timet. Since d1fdt = {381/N- J-£1, for small t, d1jdt ~ {31- J-£1; 
solving this equation, 1(t) = 1(0) Exp[(/3-J-L)t], where1(0) = 1. Under these 
conditions, we can assume that 1(t) ex: R(t+ 1/ J-L}, because 1/ J-L is the average 
time for an infected individual to die. So Exp[(/3- J-L)t] = kR(t+ 1/ J-L), where 
k = 1/0.77 and 77% of infected people eventually die. 
We have data that represents the total number of dead people at timet, 
cumulative of R(t), so we fit the data with the curve. We take the natural 
log of the data so that our fit will be a linear fit: 
(/3- J-L)t = Ln[1/0.77] + Ln[R'(t + 1/ J-L)]. 
The slope of the line which best fits the data is 0.14. By substitution, 
(/3- J-L)t - Ln[R(t + 1/ J-L)], 
0.14t 
- Ln[R(t + 1/ J-L)], 
({3- J-L)t - 0.14t, 
so /3 - 0.14 + J-L. 
Since the slope of this graph is so sensitive to the number of data points used 
in the fit, an average of these slopes is used to solve for /3. This average slope 
was taken for fits for 10-20 data points. The average slope is 0.113. With 
this information we are able to calculate a range for the basic reproductive 
number 'Ro, where 'Ro = /3/ J-L. !<or our range of J-L between 1/6 and 1/31, 'Ro 
ranges from 1.57 to 5.03. We are now ready to look at the solution of the 
system of differential equations: 
d8 
-{381/N, -dt 
d1 {381 /N- JLl, -dt 
dR 
J-£1. -dt 
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Since we only have numerical solutions, we can only view the graph of 
the solutions of each of these equations (see Figure 3]. The solutions plotted 
there contain the number of susceptible at timet, S(t), the number of dead 
at timet, R(t), and the number of infected at time t, J(t). 
We want to use the relation between J(t) and R'(t) to plot I(t) to fit R'(t) 
the best. Recall that R'(t) = J.Ll, so the data being considered is fitted by J.Ll 
plus a shift of 1/ Jl· to account for the average time from infection to death. 
We first consider how J.t varies: 1/31 < J.L < 1/6. For the graphs of Figure 
4, we have taken J.L = 1/22, 1/5, and 1/30, and N(O) = 900. The respective 
graphs show exactly what one expects, since by increasing the period that 
an infected individual lives, 1/ Jl., there is an increase in the number of dead 
which the model predicts. 
The next variable that we have to take into account is N(O). The range 
for this variable is attained by taking an educated guess as to who the true 
susceptible individuals ar:e in the population. These individuals are the fam-
ily members and medicaf staff that care for the sick. This is a reasonable 
assumption since the only individuals who are at risk are those that have per-
sonal contact with the infected individuals. The lowest possible value of N(O) 
would be about 250 individuals since only 244 died in this outbreak. A possi-
ble top limit for the greatest value of N(O) could be around 900-1000, taking 
into consideration only the population size of families, health-care workers, 
and others involved in close and personal contact with infected individuals 
(refer to Figure 5]. 
The model, for larger values of N(O), overestimates the number of ex-
pected individuals that will die. This observation may give the impression 
that the model badly represents the data, but in reality this overestimation 
could be of use to health-care workers who plan for how bad an outbreak may 
become by knowing statistics about the first 1Q-20 days of the outbreak. 
2. Ebola outbreak of 1976 in Yambuku, Zaire. 
We will now model the 1976 outbreak of Ebola in Yambuku, Zaire. The 
data that we will use for this outbreak was obtained from the Center for 
Disease Control (CDC) in Atlanta, GA. We will model the total infections 
that occurred during the outbreak using a modification to the S-I-R model. 
In this model, we will differentiate between the incubation period and the 
infectious period of the disease. As before, the number of susceptible indi-
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viduals at time t will be denoted as S(t). We will refer to the incubation 
period of the disease as the latent stage. The number of latent individuals 
at timet will be denoted by E(t). Individuals that are infected with the dis-
ease and are suffering the symptoms of Ebola will be classified as infectious 
individuals. The number of infectious individuals at timet will be denoted 
by I(t). Similarly, the number of dead individuals at timet will be denoted 
by R(t). 
The population studied will be a constant population during the outbreak; 
i.e., the total population at timet will be denoted by N where N = S(t) + 
E(t) + I(t) + R(t). Our model is: 
dS 
-{JS(J + qE)/N dt -
dE {JS(J + qE)/N- 8E dt -
di 8E- ri -dt 
dR 
ri. dt -
This model takes into consideration the number of people infected due to 
direct contact with an infected individual and the number of people infected 
due to direct contact with a latent individual: {JS(I +qE)jN. In this model, 
{3 = pc where pis the probability of successfully getting infected when coming 
into contact with an infected individual, and c is the per-capita contact rate. 
The parameter q (0:::; q:::; 1) is a weight factor added to the model since it is 
known that a susceptible individual has a higher chance of getting infected 
from an infectious individual than from a latent individual [3]). 
The individuals in the latent stage eventually show the symptoms of the 
disease, and pass on to the infectious stage. This is denoted by 8E, where 
8 is the per-capita infectious rate. Then 1/8 becomes the average time for 
a latent individual to become infectious. This will be denoted by 1I, where 
1 is the per-capita death rate. Then, 1/r becomes the average time it takes 
an individual to die once he/she has entered the infectious stage. As before, 
death and recovery are taken to be the same, since there has not been a case 
in which a person who survived Ebola contracts the disease again. 
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Figure 6 shows the number of people who became infected each day during 
the outbreak in Yambuku, Zaire in 1976. From this data we can now estimate 
(3 using a similar method to the one in the previous model. To do this, we 
first make three assumptions: 
Assumption 1: In the beginning of the epidemic, N(t) = S(t). 
Assumption 2: Initially, there is a constant number of individuals infected. 
Those individuals infect other individuals who become latent. It takes 1/8 
days for the latent individuals to become infectious. Therefore, for the first 
1/8 days, the rate of change of the infectious individuals is 0 (i.e., di / dt = 0.) 
Assumption 3: In order for an individual to become infectious, they must 
pass through the latent stage. Thus, the data for the latent stage is the same 
as the data for the infectious stage, the only difference being that the latent 
stage data occurred 1/8 days before. Since 1/8 is the average time it takes 
for a latent individual to become infectious, and the latent stage ranges from 
2 to 21 days, we choose 1/8 = 12. Similarly, since 1/1 is the average time it 
takes for an infectious individual to die, and of the infectious stage ranges 4 
to 10 days, 1/1 = 7. Thus, we then look at the following equation to estimate 
(3: 
dE (JS(I + qE)/N- 8E -dt 
dE (J(I + qE)- 8E (*) dt -
by the first assumption; 
di 
8E- 1I = 0 ==? 8E = 1I ==? I= 8E /1 -dt 
by the second assumption. 
If we substitute I into*, then dEjdt = [(3(8/1- 8)]E. 
The information for dE/ dt is given by the daily infection data; the infor-
mation for E is the cumulative of the daily infection data. Thus, we have a 
linear relationship, and we can estimate the slope by doing a linear fit. Using 
Mathematica and the data for the first 12 days, we obtain the fit shown in 
Figure 7 where equation of the line is 0.3893t. Thus, we now have the slope 
of the best fit line, and (3 = (0.3893 + 8)/(8/! + q) = 0.567114, if we take 
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q = 0.25 and the values of b and 1 given above. The choice for q is arbitrary 
and is picked so that the model best fits the supplied data. 
Another important number that needs to be computed is the basic repro-
ductive number, 1?..0 . This number tells us how fast the disease will spread 
at the beginning of the epidemic. To calculate the value for 1?..0 , we need to 
find the Jacobian matrix of the system of equations. We then evaluate it at 
the disease-free state. Since the four- dimensional system can be reduced to 
a three-dimensional system, only the first three equations need to be consid-
ered. It is easy to show that the disease-free state is (S, E, I, R) = (N, 0, 0, 0). 
Once the Jacobian is evaluated at this point, the determinant and the trace 
must both be greater than zero to insure that the disease-free state is an 
unstable fixed point. Once all of this is accomplished, we obtain a value for 
Ro: 
Ro = (!31!)(1 + q1lb) = 5.67. 
All the parameter values are known, and thus we can solve our system of 
differential equations. The system of differential equations cannot be solved 
explicitly, so Mathematica is used to solve the system numerically. Figure 8 
shows two numerical solutions to the system plotted with the initial infectious 
data. Note the label of the axes. It reads "Positive Part of dl I dt" because the 
given data only takes into account the recruitment rate of infectious people. 
The data does not reflect the infectious individuals that die; therefore, only 
the positive part of di I dt is plotted. As can be seen in the plots, the numerical 
solutions are very good in the first part of the epidemic. After the peak is 
reached, the model is not very accurate. 
3. Ideas for Future Research. 
Both of the models that were presented in this research project used a 
constant effective contact rate, {3. This is probably not the best model for 
{3 since the probability of contracting the Ebola virus varies as the disease 
becomes more widespread. People are more careful with whom they have 
contact, and thus the number of contacts decreases as time elapses or as the 
number of infected increases. Therefore, it makes sense to have {3 decrease. 
Another idea for enhancing the model is to consider quarantine. When in-
fected people are isolated, the number of contacts that can transmit the 
disease decreases. This is something that could be taken into account in 
future work with these models. 
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More research needs to be conducted to estimate N, the total population. 
A good number for N is very important, since as it. varies, the accuracy of 
the model also varies, as was seen in the numerical solutions of the models. 
Information that may prove helpful in estimating N includes the number of 
staff members in hospitals, family size, and other data that may help deter-
mine the total susceptible population at the beginning of an Ebola outbreak. 
Research on q is also essential. It is intuitively clear that individuals 
showing symptoms of the Ebola disease are more infectious than latent in-
dividuals who show no symptoms. Therefore, a better value for q would 
make the model more accurate in predicting the dynamics of a future Ebola 
outbreak. 
4. Conclusions. 
The calculated R 0 values ranged from 2.6 to 8.6 for the Yambuku, Zaire 
outbreak in 1976; meanwhile the range for R 0 for the 1995 epidemic in Kik-
wit, Zaire was slightly lower: 1.57 ~ R 0 ~ 5.03. This makes sense since it 
shows that Ebola patients were infected more during the first epidemic due 
to misunderstanding and misdiagnosis of the Ebola virus. The values calcu-
lated for the basic reproductive number were lower than one may expect for 
Ebola, and were lower than for other diseases. For example, R 0 ranged from 
16-18 for the measles in England and Wales between 1950-68; and R 0 for 
HIV in Hampara, Uganda for heterosexuals between 1985-7 was 10-11 (An-
derson and May, 1991). This may be due to Ebola's method of transmission 
and the fear people have of contracting Ebola. 
These models are very important because they can put an upper bound 
on the number of deaths, and thus can help health officials plan for the latter 
part of an outbreak by calculating the parameters from the data at the start 
of the epidemic. The number of deaths can also be minimized by altering 
the environment; i.e., lowering {3 (the effective contact rate). This can be 
accomplished by implementing quarantine. 
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ABSTRACT. In this paper we consider a stochastic spatial SIR (Susceptible-
Infectious-Recovered) model. We assume that the population is distributed 
in separate cells. The disease is transmitted within the cell by direct contact, 
and from cell to cell through an external object (vector or vehicle) capable 
of carrying the disease. We simulate this model in a 10 x 10 grid of cells, 
and investigate the effects of the relative rates of transmission within and 
between cells on the predictability and progression of the disease. Results 
of simulation indicate that as the rate of intercellular transmission increases 
relative to intracellular transmission, the mean number becoming effected 
within each cell increases but so does the spatial variability. We also found 
that the time for the epidemic to run its course reaches a maximum average 
value at intermediate relative rates as does the spatial variability. 
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1. Introduction 
The common mathematical models for diseases are the SIS (Susceptible-
Infectious-Recovered) models, developed by Kermack and McKendrick (see 
discussion in [2), [5] and [6]). In the case when infective individuals recover 
and again become susceptible to the disease, the model used is the SIS. In the 
case when infective individuals recover and attain permanent immunity, we 
use an SIR model. The classical models do not consider how the population 
is distributed in space, only the number of individuals in each class. 
In this paper we describe a spatially discrete model, and simulate this 
model in a 10 x 10 grid of cells. The effects of the relative rates of transmission 
within and between cells on the predictability and progression of the disease 
are investigated. 
2. The Spatial Model 
The classical SIS and SIR models do not take into account how the indi-
viduals are distributed in space. However, spatial models have been studied. 
For instance, D. G. Kendall (see discussion in [1] and [2]) formulated the 
following model: assuming that the individuals are continuously distributed 
on a region of the plane with density a individuals per unit area, S(x, y, t), 
I(x, y, t), and R(.-r, y, t) being the density of susceptible, infectious and re-
covered individuals, respectively, at point (x, y) and at time t, we have the 
equations 
oS(x, y, t) 
at 
ol(x, y, t) 
at 
oR(x, y, t) 
at 
- -(3S(x, y, t) I(x, y, t) 
- (3S(x, y, t) I(x, y, t) - 1I(x, y, t) 
- :I(x, y, t) 
where (3 is the infection rate, "( is the recovery rate, and (I) is a spatially 
weighted average of I given by 
(I)(x, y, t) = J J W [(x'- x), (y'- y)] I(x', y', t) dx'dy', 
W being an appropriate nonnegative weighting coefficient satisfying 
J J W [(x'- x), (y'- y)] dx'dy' = 1. 
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The model above assumes a continuous distributed population. In this paper, 
however, we will consider the case in which the population is distributed in 
separate cells. 
We assume that the population is distributed in a grid of cells. The 
individuals inside each cell are free to move within their cell, but there is 
no direct contact (contagion) among the individuals of different cells. The 
infection is transmitted within cells at rate (3, and between cells by a vector or 
vehicle at transmission rate a. Individuals recover with a rate 1 and become 
immune to the disease. We also assume that the dynamics of the disease are 
on a fast time scale compared to the birth and death rates of the population 
so that the population can be considered fixed. Then we have the following 
deterministic version of the model describing this system: 
dSx,y 
dt 
dfx,y 
dt 
dRx,y 
dt 
- - (f31x,y +a LW(k, m)Ix+k,y+m) ~x,y 
k,m x,y 
( f31x,y + Q L W(k, m)Ix+k,y+m) ~x,y - llx,y 
k~ X~ 
where Nx,y = Sx,y + lx,y + Rx,y (the total number of individuals in cell (x, y)), 
Sx,y, lx,y, and Rx,y are the number of susceptible, infectious and recovered in-
dividuals, respectively, and W is a nonnegative weighting function satisfying 
Lk,m. W(k, m) = 1. 
The above model is quite general for most spatial processes where popu-
latins are confined locally or migration is on a longer time scale than that of 
the disease. Examples are diseases in breeding farms, where the affected an-
imals are confined but transmission can take place by pests or vehicles such 
as maintenance tools or feed. This model could also be applied to hospitals, 
where a disease could be transmitted between wards by staff or visitors. 
3. Simulations 
The stochastic version of the above model is too complicated to be stud-
ied analytically. Computer simulations are an alternative of studying com-
plicated systems such as this. In our model a, (3 and 1 are as above, and 
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we assume that a cell can only be infected by it!:i four immediate neighbors 
(nondiagonal), as the next diagram shows: 
In the diagram we represent the process inside each cell ( x, y) as sus-
ceptibles becoming infected, and after a time recovering and then becoming 
immune to the disease. The dotted lines represent indirect transmission of 
the disease from the neighboring cells. This particular case is then described 
by the set of equations 
dSx,y 
dt 
dlx,y 
dt 
( 0' ~ ·) Sx,y 
- - f31x,y + 4 ~Jk,m N 
( 0' ~ ) Sx,y 
- f31x,y + 4 ~ h,m N - 'Yfx,y 
dRx,y _ 
dt 
where the sum is taken over the four immediate neighbors of cell (x, y). Note 
that here { t k = ±1 W(k, m) = 4 k = 0 
0 otherwise 
m=O 
m=±1 
since we are assuming that all contiguous cells have equal weight with respect 
to direction in the external transmission of the disease. The grid size was 
10 x 10 on a torus. To simulate the stochastic process, then, we define the 
following: 
Call the rate of infection B. Then 
( 0' ~ ) Sx,y Bx,y = f3lx,y + 4 ~ h,m N 
and call the rate of recovery D. Then Dx,y = 'Ylx,y· The total event rate is 
then L: Bx,y + Dx,y or equivalently the mean time between events is 
T = (L Bx,y + Dx,y) -l 
x,y 
The time between events (the inter-event times) can be simulated as an 
exponential with S = -Tln(UI) where U1 is a uniform (0,1) random variable. 
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The event occurs in a particular cell ( i, j) if a second unform random variable 
(U2) is 
"'i-l,j-1 (B + D ) "'i,j (B + D ) L..,x,y x,y x,y < u2 < L..,x,y x,y x,y . 
L~;;(Bx,y + Dx,y) - L~;~(Bx,y + Dx,y) 
The probability of an infection given that an event has occurred = Bi,jT and 
the probability of a recovery given that an event has occurred = Di,jT. Then 
to decide if the event is an infection or a recovery we pick a third uniform 
random variable (U3 ) and if 
B·· 0 < u t,J 
-
3 < B· · D· ·' t,J + t,J 
then Si,j ~ Si,j -1, hj--+ Ji,j + 1, and R,j ~ Ri,j (an infection occurs) 
and if 
B-· 
t,J < u < 1 
B··+D··- 3 - ' t,) t,J 
then Si,j ~ Si,j, hj ~ Ii,j -1, and Ri,j ~ Ri,j + 1 (a recovery occurs). 
We simulated the system with initial conditions 15,5 = I and lx,y = 0 
for all other (x, y), and Rx,y = 0 for all x and y. Figure 1 represents the 
results after 100 simulations for several pairs (G., {3) with 1 = 1 and N = 10. 
Setting "/ = 1 changes our time units to the mean recovery period. The 
surfaces represent the average number of survivors (individuals who remained 
susceptible during the whole development of the epidemic), the average times 
for the epidemic to finish, the average maximum of infectious individuals at 
a certain time and the average time when this maximum occurs. The colors 
represent the variance of the results. 
Figure 1 shows the effects that the parameters 0'. and {3 have on the 
system. Our choice of parameter values was severely limited by computer 
time for large values of 0'. and {3. In order to better understand the effect of 
the parameters on the model we established the following relationship. The 
basic reproduction number for the development of the infection inside an 
isolated cell is given by R 0 = !3/r· The spatial aspect of the problem leads 
toR~= ({3 + G.)/r· 
We define the spatial infection number S0 by 
0'. 
So= (3' 
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the quotient between the transmission rates inside and outside the cells, 
which can be interpreted as the ability of the disease to spread throughout 
the cells. We can then write 'R~ = (1 + S0 ) !3/'Y = (1 + S0 )'R0 . 
Figures 2, 3, 4 and 5 show the results after 100 simulations with 'Y = 1 and 
N = 10, for the values of 'R0 = 1, 2, 4 and 8 (since "'f = 1 these correspond to 
the values of {3 = 1, 2, 4 and 8), and the values of S0 = 1/100, 1/200, 1/400, 
1/800·and 1/1600. The points plotted are the values of a that correspond 
to the values of So mentioned above and the average results after the set of 
simulations, where the calculations correspond to the same calculations as in 
Figure 1. The vertical lines represent one standard deviation of the data. 
Note that for 'Ro = 1 (Figure 2) the average times for the disease to 
die out are around 1, since we just need to wait for the infected individual 
to recover. As we increase 'Ro, we see that an epidemic develops, and that 
as we increase S0 the number of survivors (those that never contract the 
disease) decreases, since the disease attacks more cells. Note that for 'Ro = 8 
(Figure 5), as we increase the value of S0 , the time for the epidemic to finish 
decreases, assuming a maximum of around 15 at S0 = 1/400. This means 
that So also tells us the speed of the development of the epidemic. Note that 
the epidemic finishes with maximum average time of 15 recovery periods. 
Simulations of the stochastic process lead to two interesting conclusions. 
First, even though the spatial aspect of the infection leads to lower num-
bers of survivors as the spatial infection number increases (the result one 
would expect from the deterministic process), the variability of the number 
of survivors increases even more dramatically. And second, the time for the 
infection to run its course reaches a maximum of variability at. intermediate 
values of the spatial infection number. 
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Abstract 
Antiviral drugs have been known to prolong the lives of HIV infected 
patients. However, it is still uncertain if antiviral drugs affect the rate of 
virion clearance, the loss of target cells, or both. In this study, we used 
mathematical models to measure the effects of a protease inhibitor on three 
infected patients. After analysis of this data, we were able to calculate the 
lifespans of free virions and infected cells. We found that the antiviral drug 
decreased not only the number of free virions in the plasma but also the loss 
of infected target cells. Although this antiviral drug is not a cure for this 
disease, it can provide insight into creating an effective treatment program 
for HIV patients. 
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1 Introduction 
Researchers have been trying to understand why the human immunodefi-
ciency virus (HIV) leads to the collapse of the immune system. One hypoth-
esis is that HIV destroys target cells that have CD4 receptors. These target 
cells, or white blood cells, are crucial to the immune system. Once infected, 
a target cell becomes a virus-producing cell. After about seven hours, the 
target cell releases free virions into the plasma either by budding or erupting. 
In a recent study, plasma levels of HIV -1 were shown to decrease expo-
nentially after an antiviral drug was administered to five patients (Ho et al. 
1996). The antiviral drug, known as Ritonavir, is a protease inhibitor that 
prevents the virus from producing core proteins necessary for viral infection. 
These core proteins include RNA, gag, and pol proteins (Schupbach 1990). 
Ritonavir has only been on the market since 1996. Since Ritonavir's lifes-
pan is only 8-10 hours, HIV patients need to take the drug consistently; the 
recommended dosage is 600mg twice a day (Ad). 
Our project initially studied the dynamics of HIV-1 replication rate using 
what we will refer to as the P-Model (Ho et al. 1996). Our main purpose was 
to estimate the clearance rate and the lifespan of free virions and infected T 
cells on simulated data from three patients over a ten-day period. By analyz-
ing the derivation of the P-Model, we were able to determine its efficiency for 
explaining the behavior of HIV replication. We realized that the P-Model's 
efficiency depends upon many unrealistic assumptions, and decided to take 
our research further. We came up with a model that takes into account the 
drug's efficiency, the fact that T cells replicate, and that there is an immune 
response. 
What we call the L-Model is 
dT/dt A- kVTjP- ~-tT + qkVT/P (1) 
Before treatment dT* fdt (1-q)kVT/P-8T* (2) 
dVfdt N8T*- cV- qNkVTfP (3) 
dT/dt A- kv1T/P- ~-tT + qkV!T/P ( 4) 
After treatment dT* fdt (1- q)kV!T / P- (r + 8)T* (5) 
dV1 /dt ¢N8T* - CVI- qilkVlT I p (6) 
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(7) 
where the total concentration of virions in the plasma is V ( t) = VI ( t) + V N I ( t). 
VI(t) is the plasma concentration of virions in the infectious pool and VNI(t) 
is the concentration of virions in the noninfected pool. At the beginning of 
the treatment, when time is zero, \1](0) = Vo and VNI(O) = 0. 
Variables 
T 
T* 
Unknown 
the concentration of viral particles in plasma at time t. 
the plasma concentrations of virions in the infectious pool. 
produced before the drug's application, Vi(O) = Vo. 
the concentration of viral particles in the noninfectious pool. 
produced after the drug's application, Vni(O) = 0. 
target cells. 
virus-producing cells. 
N number of new virions produced per infected cell during its lifetime. 
N virions killed by each T, 
Parameters 
q proportion of successful attacks by the T cells. 
T / P probability of T cell infection. 
A constant recruitment rate. 
1-L per capita death rate. 
¢ drug efficiency. 
P total population ofT cells. 
k the rate at which HIV infects target cells. 
c the viral clearance rate. 
6 the loss rate of infected cells. 
In this paper we find a solution in terms of \t0, c, and 6 for the total 
concentration of virions in the plasma at time t. We then use this solution 
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and the data to estimate c and b. Next, we compute the half life of free 
virions and interpret the average lifespan of a virion, an infected cell, and 
the average generation time of the virus. In the following section we estimate 
parameters and compare the predictions of a different model with results from 
the average lifespan of a virion, an infected cell, and the average generation 
time. We conclude with remarks on the biological implications of our results. 
2 Interpretation of the L-Model 
What we have named the L-Model is an extension of our initial project. It 
takes into account the T cells' dynamics and the immune system's defense 
reaction; therefore, it includes such factors as the rate of change ofT cells, the 
recruitment rate, the mortality rate of T cells, and the number of successful 
attacks by T cells on the virions. These important elements, omitted in the P-
Model, are now taken into account to provide a more accurate analysis. Like 
the P-Model, the L-Model contains two parts: before and after treatment. 
As we analyze the change ofT cells with respect to time, before treatment 
we see that there is a recruitment rate as well as a result of the interaction 
between the virions and the T cells. There is also a mortality rate, reducing 
the number of T cells. Successful attacks by the immune system on the 
virus reduce the number of infected T cells. Changes in the number of 
infected T cells relative to time are also affected by the loss rate of infected 
T cells. As the number of infected T cells increases, so does the number of 
virions, but as the population of virions grows there is a portion of virions 
being eliminated by the clearance rate and by the immune system's successful 
attacks. Similarly, the "after-treatment" portion of the L-Model includes an 
analysis of changes in the number of T cells with respect to time. This 
change is almost identical to the one before treatment, except that this time 
only the infectious virions affect the normal T cells. This is because the 
only virions that the T cells recognize are the initial ones. Likewise, the 
change in the number of infected T cells after treatment is similar to that 
of before treatment except that the mortality rate of T cells influences the 
number of infected T cells. There are two types of virions, the infectious and 
the noninfectious. The change in the number of infectious virions relative to 
time is related to the drug's effectiveness since the drug is not 100% effective. 
The term ¢N bT* represents infectious virions that the T cells continue to 
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attack after treatment. The number of noninfectious T cells is related to the 
drug's effectiveness and the clearance rate. 
In comparison to the P-Model, the L-Model is a better fit for reality be-
cause it relaxes most of the assumptions made in the P-Model. The L-Model 
makes only three assumptions: it assumes that the drug is administered once 
and that its effectiveness is a constant function of time; it also assumes low 
initial estimates for the number of new virions produced per infected T cell 
during its lifetime, and for the number of virions killed by one T cell. 
3 Solving for the Concentration of Virions 
By simplifying the L-Model and utilizing a few mathematical methods of 
approximation, we were able to find appropriate estimates for the viral clear-
ance rate, denoted by c, and the loss rate of infected T cells, denoted by 
8. In order to simplify the L-Model, we considered the situation when we 
have a 100% effective drug (i.e., ¢ = 0) and when the T cells are unable to 
attack the virus (i.e., q = 0). In addition, we must also make the following 
assumption for simplification purposes: T cells are initially at a quasi-steady 
state. This implies that the replication rate of T cells relative to time, in 
comparison to the replication rate of HIV-1 relative to time, is negligible 
(i.e., dT jdt = 0). Thus the number ofT cells is considered to be constant 
throughout the steady period. In dealing with such a small-time interval 
(To), we can also neglect the mortality rate of normally producing T cells 
(i.e., JlT = 0). 
Given these assumptions, we can eliminate equations (1) and (4) from 
the system, as well as any component containing¢ or q to obtain: 
Before treatment dT* jdt 
dVjdt 
dT* jdt 
After treatment dV1jdt 
dVNJ/dt 
kVT- 8T* 
N8T* -cV 
k~T- 8T* 
-cV1 
N8T*- cVNI, 
(8) 
(9) 
(10) 
(11) 
(12) 
As a result of this elimination process, we are able to derive the P-Model 
from the L-Model. With this system of five nonlinear differential equations 
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and a few assumptions, we can derive a solution for the number of virions in 
the plasma at time t. 
Several assumptions are included in this model to simplify the analysis 
of HIV's behavior under drug treatment. First of all, we assume that the 
HIV-1 virus infects a target cell at a constant rate k, at which time it takes 
on the role of a productively infected cell, T*. Second, we assume the drug is 
100% effective and that the number of target cells remains constant. Further-
more, we assume infected cells do not recover during the treatment period, 
to reduce the complications on the estimation of c and d. We also assume 
that the system describing the dynamics of HIV -1 's reproduction rate is at a 
quasi-steady state, that is, that dT* jdt = 0 and dV /dt = 0 before the drug 
treatment. This assumption may be reasonable if the uninfected cell con-
centration stays at its steady state level for approximately a week after the 
administration of llitonavir. Given these assumptions, the model becomes 
simple enough that an interpretation of the dynamics of the virus is possible 
(a caricature). 
Using the P-Model, we were able to derive a mathematical expression for 
the total concentration of virions at time t that depends only on the initial 
number of virions, V0 , the rate of virion clearance, c, and the loss rate of in-
fected cells b. To analyze the replication rate of HIV-1 under drug treatment, 
we assume that (at the moment we start the treatment) the replication rate 
of infected T cells and of virions is zero. Thus dT jdt = 0 and dVjdt = 0. We 
also assume that the level, T0 , remains constant for the first week after the 
drug is administered. In other words, we assume that T remains at a steady 
state for one week after the drug is administered. 
Then we obtain the number of infectious virions V ( t) by using separation 
of variables to integrate equation (11): 
1VI(t) dVI 
Vo V1 
lot -edt 
0 . 
ln IVIII~~(t) 
-ct ~~ 
=> ln IVI(t)l -ln IVol -ct 
ln I V~t) I -ct (13) 
lnl VJ(t) I 
e vo ect 
6 
IV1(t)l l'O 
V1(t) Vr -ct oe . 
Next, in order to find the number of noninfectious virions in the plasma, we 
solve equations (10) and (12). First we solve for T* after we substitute our 
last result for V](t) into equation (10) 
dT* = kVr0e-ctT- 8T dt ' 
and since T is constant then 
d~* = k Voe -etTa - 8T*. 
Using the integrating factor technique yields 
dT* 
eotdt + 8e6tT* = kVoe6-ctTo. 
This expression can be written 
::::? :t (T*e6t) = kVoToe6-ct. 
Changing the variable of integration we get 
T*(t)e6t- T*(O) 
T*(t)e6t 
T*(t) 
T*(t) = 
kt kVoToe({)-c)sds 
kVoTo (et(6-c)- 1) 
8-c 
kVoTo (et(6-c)- 1) + T*(O) 
8-c 
[~~~ (e'(6-L 1) +T;] e-" 
[kVoTo ( et({)-c)- 1) + (8- c)T~l 
8-c 
where T~ is the initial value of T*(t). 
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(14) 
Assuming that we are in a quasi steady-state so that dT* jdt = 0, it 
follows from equation (8) that if T0, V0 , and To are the initial conditions of 
T*, V, and T, respectively, then kdV0T0 = 8T0. Making this substitution, 
equation (14) becomes 
T*(t) = [
[T08 (et(.5-c)- 1) + (8- c)T0)] 
8-c 
8-c 
T.* 
_o_ (8e-ct _ ce-8t). 
8-c 
-6t 
e ' (15) 
Next we substitute this expression for T*(t) into equation (12) and solve for 
VN1 (t), obtaining the number of noninfectious virions in the plasma: 
dVNI 
--+cVNI dt 
N8 ( r; (8e-6t- ce-8t)) - cVNI 
8-c 
N8To(~ -ct) N8To( -6t) TT 
-- ue --- ce -cvNI 8-c 8-c 
N8T0 (8e-ct) _ N8T0 (ce-8t). 
8-c 8-c 
Using the integrating factor technique yields 
8-c 
N82To ct -6t 
~ ce e 
u-c 
lot N 82To d lot N 8To (c-8)t s- --ce ds 
o 8-c o 8-c 
VN1ect = ~ -1- e c-.5 t since VNI(O) = 0. N82T.•t ( ) ( ) 6-c c-6 ' 
(16) 
Now equation (9) and dVjdt = 0 implies N8T0 
substitution equation (16) can be rewritten as 
cVo, and with this 
VNI(t) = --0 8te-ct- -- + --N 8T.* ( ce-6t ce-ct) 8-c 8-c c-8 
8 
N 8Tr; (bte- ct _ ____!:___ (e-ot e- ct) ) 
t5-c t5-c 
-- -- e -e -ute Nt5TJ ( C ( -ot -ct) $; ct 
c-t5 8-c 
VNI(t) = do (-c-(e-6t- e-ct) - 8te-ct. 
c-t5 c-8 
(17) 
Hence, using equations (13) and {17) the total number of virions in the 
plasma at time t 
can be expressed as 
V(t) = Voe-ct + cVo (-c-(e-ct- bte-ct). 
c-t5 c-8 
Given this solution, we can obtain appropriate values for the parameters for c 
and 8 using various mathematical techniques. This work is described below. 
4 Estimation of c and 8 
We estimated the clearance rate of virions and the loss rate of infected 
cells by using the Mathematica's packages NonlinearFit, Statistica Nonlinear 
Regression Analysis, Least Squares Method, and Find Minimum Program. 
The Mathematica NonlinearFit Package applies internally to Quasi New-
ton's Method, which gives the best approximations for the parameters of 
nonlinear multivariable equations. Here we entered the data of virions pro-
duced for all three patients. For each patient, we found estimates for V0 , c, 
and b, using the solution of V(t) and giving initial estimates to these pa-
rameters. We then computed the average estimates for V0 , c, and 8. These 
approximations enabled us to graph the P-Model by plotting the average pre-
dicted values. Finally. we used Mathematica to compute the relative error of 
the P-Model with respect to the data observed, applying the relative error 
formula to the data of each patient. Thus, we obtained converging values 
for every parameter with a minimum error. Similarly, the Statistica Non-
linear Regression analysis package provided these minimum estimates, but 
for a more complicated case. The Regression Analysis Package, unlike the 
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NonlinearFit, applied the Quasi Newton's Method to the observed data for 
all patients simultaneously. As a result, it yielded the average estimates of 
the parameters. The FindMinimum program, unlike the two aforementioned 
methods, takes much longer and incorporates more steps to compute the best 
parameter approximations. 
5 Graphical Analysis of the Latino and Perel-
som Models 
The decline that occurs in the number of virions in the plasma after the 
drug is administered to the three patients can be interpreted graphically. By 
graphing the solution to the P-Model V(t) and using the obtained average 
parameter values of c, 6, and the initial number of virions, Vo, we observe an 
exponential decay in the number of virons as time progresses (see Figure 1). 
Initially we see a delay in the decline of virions, followed by a rapid, 
then a slower, decline. The delay that occurs in the first few hours is due 
to the amount of time needed for the drug's absorption, distribution, and 
penetration. The slow rate of decay in the number of virions during the 
last hours of the treatment period results from the dissipation of the drug's 
concentration. 
By comparing the predicted data with the observed data we can conclude 
that the P-Model, under the assumptions made, accurately describes the 
replication dynamics of HIV-1. This model provides a well-fitting curve for 
the observed data of each of the patients (Figures 2a-2c). The deviation from 
the curve to the observed data is almost insignificant, yet as we approach the 
end of the 10-day trial period this deviation increases. The efficiency of this 
model for all three cases under study is reflected in the relative error rate of 
each patient. As time goes by, the relative error for each patient increases 
(Table 1). 
We used Matlab to simulate our model. We created a program to find the 
best number of parameters fork,¢, and q, then we graphed the functions of 
l [, T, T*, and l' N 1 to see the behavior of the graphs. Finally, we analyzed 
the graphs to see if these behaviors are consistent with biological behavior. 
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6 Comparison of the P-Model to the Wei et 
al. Model 
11(t;c,8) = [Vo/(c- 8)] (ce-6t- 8e-ct) (18) 
This model was introduced by Wei et al. (1995) and its symmetrical formula-
tion does not allow us to distinguish between the viral clearance rate and the 
loss rate of infected T cells. In addition to this ambiguity involved in finding 
parametric values for c and 8, we find that the nonlinear regression analysis 
utilized in finding estimates for c and d in the P-Model is not suitable for 
this model. Consequently, use of this data-fitting procedure in the Wei et 
al. (1995) model only establishes the fact that it is sensitive to the initial 
conditions chosen; that is, a slight alteration of the initial conditions for c 
and 8 yields entirely different results for their minimum values as processed 
by the NonlinearFit package. 
In order to demonstrate the limitations of equation (18) for distinguishing 
the parameters c and 8, we observe that V(t; c, 8) = V(t; 8, c). Therefore, if 
we tried to compute values for c and 8 we would not be able to distinguish 
between them. 
7 Analysis of the Drug's Effectiveness ( ¢) Ac-
cording to the L-Model 
When the drug is 100% effective¢= 0, and when the drug is completely 
ineffective ¢ = 1. Therefore, as ¢ approaches 1 (i.e., as the drug loses its 
efficiency), the number of noninfectious virions approaches zero. This implies 
that at¢= 1 the drug's effectiveness has ceased, thereby causing the patients 
to revert to their condition before treatment. 
The drug's effectiveness eventually diminishes (i.e., ¢--+ 1). With time 
the virus builds resistance and the drug's concentration in the blood stream 
vanishes. In order for the patients not to return to their condition before 
treatment, we must administer the drug periodically. Since the drug's effec-
tiveness changes periodically with time, it must contain a periodic component 
accounting for the resistance it encounters, ¢. 
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After administering a protease inhibitor drug Ritonavir in two different 
strengths, the percentages of infectious virions ( \!1), noninfectious virions 
(VNI ), T cells (T), and infectious viron-producing T-cells (T*) change. This 
variation is directly affected by the strength of the drug. Histograms allow us 
to approximate the percentages of virions and cells, and also explain Graph 
1. 
Analyzing the number of virions before treatment (Histogram 1), we ob-
serve that all of the virions produced before the drug's administration are 
infectious (Vi). In analyzing the number of infected and noninfected T cells 
before the drug, we assume that 100% of the cells before treatment are pro-
ducing only infectious virions. After the drug is administered, we divide our 
observations into two categories: the first one is when we have a drug that is 
99% effective, and the second one is when the drug is 10% effective. When 
we use a 99% effective drug, we observe the percentage of healthy T-cells is 
greater. This is because the drug is stopping the production of infectious 
virions; therefore, there are not enough virions to infect T-cells. 
In Histogram 2a, we use an extremely efficient drug (99% effective). A 
drug this efficient will transform cells from infectious virion-producing (T*) 
to noninfectious viron-producing cells (T). The greater number of T will 
show a large population of VNI· On the other hand, in Histogram 2b, when 
the drug is only 10% effective, the percentage of infected virions will be 
higher than the noninfected ones (mainly because of the drug's inefficency in 
protecting cells from becoming T*). By lli3ing a less effective drug, we have 
a tremendous production of infectious virions (Vi); these virions will infect a 
greater number ofT-cells, consequenly converting them into infectious T-cells 
(T*) at a fast rate. 
Results 
Figure 1 measures the predicted values for the number of free virions in 
the plasma over a 10-day period. If we use the P-Model, we expect to see an 
initial delay followed by a rapid then a slow decrease in the number of free 
virions. This initial delay is less than a day. The number of virions decreases 
to zero at the end of 10 days. 
In Figures 2a-2c, the observed and predicted values are plotted for the 
three patients. The number of free virions does decrease over time. These 
results are consistent with our predicted values (refer to Figure 1 for the 
predicted values). 
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Figure 3 measures the predicted number of infected vmons when the 
drug's efficiency is 10%, 50%, and 99%. The dashed curve represents the 
drug's efficiency when it is 99%, the middle curve when it is 50%, and the 
top curve when it is 10%. Q represents the number of successful attacks by 
T cells when the T cell count is 1%. When the drug's efficiency is 99%, the 
number of infected virions approaches zero after two days. The number of 
infected virions is significantly higher when the drug's efficiency is 10 
Figure 4 measures the predicted number of noninfectious virions for drug 
efficiencies of 10%, 50%, and 99%. When the drug is 99% effective, the 
number of noninfectious virions reaches a peak of 15 virions 1.5 days after 
treatment. Then there is a slow decline in the number of noninfectious virions 
over the 10-day period. The peak only reaches eight noninfectious virions for 
a drug efficiency of 50%, and two noninfectious virions for a drug efficiency 
of 10%. 
Figure 5 measures the predicted number ofT cells using the same drug. 
When the drug's efficiency is 99%, the T cell count remains constant at a 
value of 1.3295 X 104 cells. 
Figure 6 measures the predicted number of infected T cells. When the 
drug is 99% efficient, the number of infected T cells approaches zero. This 
occurs six days after drug treatment. When the drug is 50% effective, there is 
a gradual decrease in the number of infected T cells. However, there are still 
10 infected T cells remaining after 10 days of drug treatment. The number 
of infected T cells increases when the drug is 10% effective. 
8 Conclusion 
We look upon the work done here as only the beginning of an on-going 
learning process. Thus our work is not entirely conclusive. With this in 
mind, we offer to those individuals interested in expanding on our work some 
suggestions for improving the accuracy of our model. First, it is important to 
consider the long-term effects and treatment process for the antiviral drug. 
A long-term model would focus on the dynamics of HIV and include HIV's 
density, mutation rate, and drug resistance. Since HIV becomes resistant 
to llitonavir, it is important to continue applying the drug. Reapplication 
can be modeled as a periodic funtion of time for the drug's effectiveness. 
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Graphically, we would expect to get a cyclic function which repeats itself 
every time the drug is applied. Over time, the total number of virions and 
infected T cells declines, but as soon as HIV builds resistance, the number 
of virions will increase dramatically. Therefore, if we consider a long-term 
effect we will expect a cyclic funtion which initially decreases then increases 
rapidly. 
To bring this model closer to reality, it is also essential to increase the 
sample size. Another suggestion for further research would be to administer 
more than one drug during the period of study. Although the list of ideas for 
further study is not exhaustive, we leave the generation of more interesting 
additions to our list up to the curious scientist in all of us. 
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Abstract 
This study examines a mathematical model in which a vaccine without 
complete effectiveness is applied to a core group. The prevalence of the dis-
ease within the core group determines the recruitment rate into the core 
group. The recruitment function in this model is set up for the case depen-
dent on the proportion of infectious individuals. In particular, we study the 
possible oscillations of the disease over time caused by the vaccination rate 
and vaccine efficiency. 
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Introduction 
Induced immunity against infectious diseases has been a primary con-
cern for centuries, from the inoculation of individuals in the Ming dynasty 
to Edward Jenner's small pox vaccination. In the late 1700's, during the 
widespread European epidemic of small pox, Jenner observed milkmaids' im-
munity to small pox. Further investigation revealed that the microbe species 
infecting cows with cow pox was closely related to small pox. Vaccination 
originated when Jenner inoculated susceptible individuals, persons capable of 
becoming infected, to induce small pox immunity with material taken from a 
pustular cow pox lesion. In 1760, Daniel Bernoulli introduced the first math-
ematical model to study the spread of infectious diseases and the benefits of 
vaccination. 
A vaccine provides either permanent or temporary immunity. Success-
ful implementation of a vaccination strategy will ultimately result in disease 
eradication. However, a vaccine can adopt any of the following properties: 
permanent immunity and complete effectiveness, temporary immunity and 
complete effectiveness; permanent immunity and partial effectiveness or tem-
porary immunity and partial effectiveness. 
Social relevance of vaccination models is significant. Vaccination models 
are used by health care officials to combat an infectious disease epidemic. 
Viruses do not recognize geographical or political borders. As a result, most 
successful disease eradication programs require cooperation of international, 
governmental, and local officials. Vaccination models are applied to improve 
the management of financial and human resources; vaccinating the core group 
requires less financial effort than vaccinating an entire population. 
Our research examines the effects of a vaccination in a core group model. 
A core group is a subgroup of the population whose members are more prone 
to becoming infected and transmitting the disease. The concept of core 
group was first introduced by Hethcote and Yorke {1984), who studied ef-
fective treatment methods for gonorrhea in a prostitute core group. The 
results enabled limited financial resources to be used efficiently to control 
the epidemic. 
Our research will incorporate vaccination into a similar model studied by 
Velasco-Hernandez, Brauer, and Castillo-Chavez {1996), in order to explore 
the behavior of a disease as the vaccination rate and the vaccine inefficiency 
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vary. This study is organized as follows: Section A defines and describes the 
equations used in this model; Section B describes computation and analysis 
of the basic reproductive number and the disease-free equilibrium; Section C 
proves the numerical existence of an endemic equilibrium; Section D includes 
graphical interpretations of the model; Section E considers death induced by 
disease; Section F concludes the paper and presents limitations to the model. 
Section A: The Model 
Let S, I and V represent the population size of susceptible, infected and 
vaccinated individuals respectively in the core group. The model equation is 
as follows: 
dS Ae-(1/N) - J-LS- ¢S- {3S !_ 
dt N 
di I I (*) dt {3S-- J-LI + CJ{3V-N N 
dV I 
dt ¢S- J-LV- CJ/3-N. 
Let the population of the core group be denoted by N, where N = S + 
I + V. The susceptible individuals become infected through contact with 
infected individuals at a rate {3. Susceptible individuals are vaccinated at a 
rate ¢individuals per unit time. Although the vaccination is permanent, it 
is not completely effective. As a result, there exists a group of vaccinated 
susceptibles. Vaccine inefficiency is measured by CJ, where 0 < CJ < 1. If 
CJ = 0 the vaccine is one hundred percent effective and if CJ = 1, the vaccine 
is completely ineffective. The natural mortality rate is represented by J-L. A 
is the recruitment rate of susceptible individuals into the core group from the 
general population. The fear or information factor affecting the recruitment 
of the non-core group into the core group is defined as a:. 
The following compartmental diagram schematically illustrates the model. 
S ~ I ~ V 
The rate of change of the population of susceptible individuals is deter-
mined by the product of the constant recruitment rate (A) and the prevalence-
dependent factor (e-ai/N) less the sum of the natural mortality of suscepti-
bles. the number of vaccinated susceptibles, and the number of susceptibles 
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becoming infected. The rate of change of the population of infected individ-
uals consists of the sum of susceptibles becoming infected and the number 
of vaccinated individuals who became infected less the natural mortality of 
the infected individuals. The rate of change of the population of vaccinated 
individuals consists of vaccinated susceptibles less the individuals who die 
naturally and those who become infected. The inefficiency of a vaccine di-
rectly contributes to the sum of infected individuals, because the ineffective 
vaccine causes the susceptible individual to become infected through contact 
with infectious individuals. 
In order to simplify the model several assumptions were made: 
• Infectious individuals die at the same rate as susceptible and vaccinated 
individuals. 
• Disease induced death was not taken into consideration. 
• The number of infected individuals outside the core-group is negligible; 
there is no chance that an infected individual will join the core group. 
Section B: Reproductive Number 
The analysis of the model begins with the computation of the basic repro-
ductive number R3. The basic reproductive number expresses the average 
number of individuals that an infectious person infects when he/she is in-
troduced into a population that is previously uninfected. Since Ro assumes 
an initially uninfected population, we begin by computing the disease-free 
equilibrium (S0,I0 , V0 ). Since R assumes an initially uninfected population, 
we begin by computing the disease-free equilibrium, (S0 , 10 , Vo) T. 
( 
11.e-f3SifN ) 
p.+<P 
F(S, J, V) = f3SI+uf3VI/N . 
<fJ-u/VI/N 
p. 
Since (So, Io, Vo) T is the fixed point ofF for which 10 = 0, it follows that 
(So, Io, Vo) = ( 
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where N = !1(= So+ Io + Vo). 
J.l. 
The dominant eigenvalue of the Jacobian matrix ofF, J, evaluated at 
the disease-free equilibrium reveals the basic reproductive number. 
The resulting dominant eigenvalue, which is also the basic reproductive num-
ber, R, is f31J-L (J-L + a¢)1(J-L + ¢). Since vaccination is considered in this 
model, R is taken as a function of ¢, the vaccination rate, and a, the ineffi-
ciency of the vaccination such that: 
If R( ¢,a) < 1 then the disease-free equilibrium, (So,!), V0 ) T, is asymptoti-
cally stable. Considering R(phi, a) when there is no vaccination (i.e., ¢ = 0) 
it is found: 
R(O,a) = f31J-L = Ro. 
Consideration of a completely ineffective vaccination, (a= 1), results in: 
R(¢, 1) = f31J-L = ~. 
Ro = (3 I J-L is the basic reproductive number of the model without vaccination. 
Notice that if (3 < J-L, the disease dies out naturally and no vaccination is 
necessary. 
Considering that · 
• 1 I J-L is the mean duration of infectiousness, 
• 1 I¢ is the mean duration of susceptibility, 
• 1I(J-L + ¢) is the average life of a susceptible, and 
• 1 I (J-L + a¢) is the average life of a vaccinated, 
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R can be rewritten as 
1/(p, + ¢) = Ro· average life as susceptible 
R(¢, u) = Ro·1/(p, + u¢) l ~ d average i e as vaccinate 
When u > 1, the vaccine increases the chance of a susceptible becoming 
infected; consequently, R)¢, u) increases. In contrast, when u < 1, the vac-
cine decreases the chance of a susceptible becoming infected, and R(¢, u) 
decreases. Infection caused by vaccination is not biologically feasible and is 
not considered relevant, thus we take u < 1. 
Section C: Endemic Equilbrium 
In th~ previous section, the disease-free equilibrium was explicitly calcu-
lated. Finding the exact expression of a single endemic point is difficult so 
that only its existence will be discussed. 
The endemic points ( S, I, V) T of the system are the fixed points of F for 
which I> 0. Setting A= I/N, the equations F ((S,I,T)T) = 0 can be 
written as: 
s 
Ae-a.r (Jsr 
---
p,+¢ p,+¢ 
I (3 (*) -(S + uV)f 
J-L 
v ¢ u(JVf - -S-
J-L J-L 
The next steps involve some manipulating of the equations in order to reach 
a single equation representing the entire system. 
so 
thus 
I + V = S((Jf + ¢) = N - S 
J-L 
SfN = 1-L 
~-t + ¢ + (Jr 
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From(*), 
¢ s f3 v 
V/N - --- oT--~-tN ~-tN 
V/N = S ( ¢ ) N J-t + uj3r . 
Since N = S + I + V, it follows that 
A = ~ = 1- (~ + ~) 
1- ~ ( 1 + J-t +~f3r) 
( J-t + : + pr) ( 1 + J-t + ~ {3r) 
(¢u/3 + !3~-t + f32ur)r 
(~-t + ¢ + pr)(~-t + u + f3r). 
For r =/- 0 (in particular we are interested in r > 0) this equation reduces to: 
r 2 + ar+ b= 0, 
where 
and 
b = J-t(J-t + ¢) - f3(J-t + u¢) f32u . 
When solving roots of r, the quadratic equation results in: 
-a± j(a2- 4b) 
r= 2 . 
Hence, to have r > 0, b < 0 is necessary: 
b < 0 
p(J-t + ¢) f3(J-t + u¢) 
< f32u 
f3 1-L + u¢) 
1 < 1-L (J-t + ¢) . 
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However, R(¢, o-) = ; <r~'+;~>; therefore, it can be concluded that an endemic 
point exists if: 
R(¢, o-) > 1. 
By introducing a vaccine into a core group, it is expected that the disease 
and the core population will coexist (note that this implies that stability 
of the endemic equilibria is expected). This coexistence will take place in 
either of two forms: one possibility is that the core population will reach a 
stable equilibrium, meaning that the population will reach a fixed proportion 
of susceptible, infected and vaccinated individuals; the second possibility is 
that the population of susceptibles, infected and vaccinated individuals will 
fluctuate. There will be a bound on how large and how small the population 
can reach. This fluctuation is what is the reoccurrence of epidemics. The 
introduction of the vaccine should attempt to stabilize the population, or if 
that is not possible, limit the fluctuation to a small range. It is crucial to 
note that the number of infectious, susceptible and vaccinated individuals is 
never zero. 
Section D: Graphical Analysis 
Case 1: 
Figure 1 depicts a vaccination rate of 0.70 with a vaccine ineffectiveness 
of 0.05. The vaccinated population increases rapidly, implying that the re-
cruitment rate and the susceptible population increase while the infected 
population decreases. A portion of the susceptible and the vaccinated pop-
ulations becomes infected because the vaccine is not completely effective. 
In this graph, the vaccinated population is larger than the susceptible 
population which in turn is larger than the infected population. Therefore, 
the infection within the core group is not eradicated, but contained by the 
vaccme. 
Figure 2 graphically represents a vaccination rate of 0. 70 and a vaccine 
inefficiency of 0.30. After the initial increase of the vaccinated population and 
the susceptible population, the infected population begins to increase. The 
spread of the infection slows the recruitment into the core group such that 
less people are susceptible and less people are vaccinated. At the minima of 
the vaccinated population, the infected population is the largest population. 
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This is due to the large vaccine inefficiency in combination with a large 
vaccination rate. 
Figure 3 shows the effect of a high vaccination rate, 0.70, with a high 
vaccine inefficiency, 0.30, and a relatively low fear factor, 3. Initially, the 
populations of the vaccinated and the susceptible individuals increase. The 
population of infected· individuals increases due to the high inefficiency of the 
vaccine. We note the recruitment rate will approach a constant value since 
a, the fear factor, is relatively small. The vaccinated population remains 
greater than the infected population and the susceptible population. 
Case 2: 
Figure 4 above displays a vaccination rate ¢ of 0.137, a vaccine ineffi-
ciency u of 0.05, and a relatively high fear factor a of 6. As recruitment rate 
decreases, all populations decrease to constant values. The infected popu-
lation is the largest of the three populations, because the vaccination rate 
is relatively low. The limit on the spread of infection is not affected by the 
vaccination of the susceptibles in the core group, and reflects an indirect 
quarantine. 
Figure 5 above graphically represents a fear factor of 6, a vaccination 
rate of 0.137, and a vaccine inefficiency of 0.30. In this graph the popula-
tions of the infected, susceptible, and vaccinated approach constant values. 
The spread of infection is also limited in this graph. The recruitment rate 
decreases because the proportion of infected individuals is high. 
Figure 6 above depicts a fear factor of 4, a vaccination rate of 0.137 and an 
inefficiency of 0.30. All populations approach constant values. However, the 
infected population is higher than the graph when the fear factor was 6. This 
behavior is attributed to the fact that the recruitment into the core group is 
less affected by the total infected population (1/N) ratio when the fear factor 
is relatively small. The recruitment into the core group approaches a higher 
constant. 
Section E: Death Induced by Disease 
One modification of the model considers death induced by infectious dis-
ease, 61. This would be the case in a disease such as HIV /AIDS (if there 
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were a vaccine for it). It is no longer assumed that infected individuals die at 
the same rate as susceptible or vaccinated individuals. Death from infectious 
disease surpasses natural mortality. It. is reasonable to assume that b > J.L. 
Only one equation changes in (*). that is 
di I I 
- = f3S- + uf3V-- (J.L + b)I dt N N 
and 
f3Sfi + uf3V fi . 
I= J.L+b . 
The disease-free equilibrium is not affected by the introduction of b. The 
resulting equilibrium remains the same: 
( ~N) (So, Io, Vo) = 0 . 
·. ......l!:._N 
J.L+<P 
The Jacobian matrix evaluated at (So, I 0 , Vo) results in: 
The only eigenvalue of J[(S0 ,10 , Vo)T] is: 
(J-L + ¢) 
The only modification in R(¢, u)b is that, instead of R(O, u) = R(¢, 1) = f3 j J.L, 
we get R(¢, u)b = Ro(¢, u)b = /3/(b + J-L). Note that 1/(b + J-L) is the average 
time an infectious individual lives before he/she dies from the disease. We 
find that with the introduction of death induced by disease, we no longer 
encounter oscillations for reasonable values of b. As b approaches zero, -bi 
becomes insignificant in dl/dt. In this case, we get our original model and 
conditions for oscillations to occur. 
Section F: Conclusion 
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The recruitment rate, A, is influenced by the fear /information factor, a, 
and by the proportion of infected individuals in the core group in the following 
manner: Ae-(a.I/N)_ Previous studies have shown that the fear/information 
factor strongly influences oscillatory behavior of a system. Fluctuating val-
ues of the recruitment rate cause these reoccurring oscillations. However, 
the prevalence dependent factor, e-(a.I/N), has two other dynamic variables 
I and N. A high percentage of infectious individuals, I jN, will cause the 
recruitment into the core group to decrease. In contrast, a lower value of 
I/ N will cause a higher recruitment. These values are directly affected by 
the rate of vaccination and the inefficiency of the vaccine. If the fear factor, 
a, is relatively large, then the system oscillates at higher amplitudes with 
increased frequencies. A relatively smaller fear factor causes smaller oscil-
latory amplitudes with smaller frequency. If individuals belonging to the 
non-core group are educated about the actual number of infected individu-
als rather than a percentage of infected individuals (i.e., eliminating N from 
the prevalence-dependent factor) then the recruitment rate will decrease and 
oscillation in the model will cease to exist. 
This model can be utilized to control and eradicate a disease in a core 
group; however, it does not take into account the disease spread in the general 
population. This model is limited by the specific application to diseases for 
which a vaccine has been developed. 
This model has some serious implications when attempting to control 
outbreaks of a disease. It is essential to consider the information people 
receive about the core population and the vaccination procedures within it. 
It can be useful to public health officials in focusing social resources to a core 
population. 
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Section D: Graphical Analysis 
Case 1: 
Figure 1 
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Figure 1 depicts a vaccination rate of 0.70 with a vaccine ineffectiveness of 0.05. The 
vaccinated population increases rapidly, implying that the recruitment rate and the susceptible 
population increase while the infected population decreases. A portion of the susceptible and 
the vaccinated populations becomes infected because the vaccine is not completely effective. 
In this graph, the vaccinated population is larger than the susceptible population which in 
turn is larger than the infected population. Therefore, the i.."lfection within the core group is not 
eradicated, but contained by the vaccine. 
Figure 2 
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Figure 2 graphically represents a vaccination efficiency rate of 0.70 with and a vaccine 
inefficiency of 0.30. After the initial increase of the vaccinated population and the susceptible 
population, the infected population begins to increase. The spread of the infection slows the 
recruitment into the core group such that less people are susceptible and less people are 
vaccinated. When the vaccinated population reaches a minimum, the infected population 
becomes largest population. 
Figure 3 
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Figure 3 shows the effect of a high vaccination rate, 0.70, with a high vaccine inefficiency, 
0.30, and a relatively low fear factor, 3. Initially, the populations of the vaccinated and the 
susceptible individuals increase. The population of infected individuals increases due to the high 
inefficiency of the vaccine. We note the recruitment rate will approach a constant value since a, 
the fear factor, is relatively small. The vaccinated population remains greater than the infected 
population and the susceptible population. 
Case 2: 
Figure 4 
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Figure 4 above displays a vaccination rate cp of 0.137, a vaccine inefficiency CJ of 0.05, 
and a relatively high fear factor a of 6. As the recruitment rate decreases, all populations 
decrease to constant values. The infected population is the largest of the three populations, 
because the vaccination rate is relatively low. The spread of infection does not seem affected by 
the vaccination of the susceptibles in the core group. 
FigureS 
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Figure 5 above graphically represents a fear factor of 6, a vaccination rate of 0.137, and a 
vaccine inefficiency of 0.30. In· this graph the populations of the infected, susceptible, and 
vaccinated approach constant values. The spread of infection is also limited in this graph. The 
recruitment rate decreases because the proportion of infected individuals is high. 
Figure 6 
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Figure 6 above depicts a fear factor of 4, a vaccination rate of 0.13 7 and an inefficiency of 
0.30. All populations approach constant values. However, the infected population is higher 
than the graph when the fear factor was 6. This behavior is attributed to the fact that the 
recruitment into the core group is less affected by the total infected population (liN) ratio when 
the fear factor is relatively small. The recruitment into the core group approaches a higher 
constant. 
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Abstract 
This paper studies the dynamics of the tick population affected by Rick-
ettsia rickettsii in order to understand how this disease affects other species. 
This project modifies the Busenberg-Cooke (BC) model to better account for 
biological aspects. Mathematical analysis assesses the effect of parameters 
on the dynamics of the model. One main result is obtained: the populations 
behavior is found to be chaotic in a region of parameter space that differs 
from that observed in the BC model. More importantly, the nature of the 
attractors seems qualitatively different. 
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1 Introduction 
The disease Rickettsia rickettsii affects many species of animals, including 
humans. This is the most important rickettsial disease for humans in the 
U.S., since there are more than 1000 reported cases per year. The most 
important vector in the transmission of this disease is the American dog 
tick (Dermacentor variabilis) which is widespread in the Northeastern U.S. 
If not treated, this disease may be fatal. The original model (proposed by 
B & C in 1982) and our modified model focus on the population dynamics 
of ticks, the main vectors of this disease. In addition to RMSF, ticks carry 
diseases such as Lyme Disease and Heartwater. Organisms that serve as 
reservoirs of the disease and live in rural areas (generally small mammals such 
as rodents) are a constant source of infection to ticks, which in turn infect 
domestic animals like dogs and rats. Domestic animals bring the infected 
ticks into close contact with humans, who are the terminal hosts of ticks. 
Dogs, however, are not efficient reservoirs of the disease since they recover 
after three days. 
The life history of the various species of ticks that carry R. rickettsi 
follows the same general pattern. However, there is a difference in the time 
required for each species to reach maturity. Some may live less than a year, 
while others have a life span of up to four years. They have three main 
life stages: larval, nymph, and adult. Larvae and nymphs feed on small 
mammals, whereas adults feed on large mammals, including humans. 
Both models-the model proposed by Busenberg and Cooke (BC model) 
and our modified model-consider two types of transmission: horizontal and 
vertical. Horizontal transmission, which depends on the host, occurs be-
tween members of the same generation of ticks, whereas vertical transmis-
sion is passed from one generation to the next. Both horizontal and vertical 
transmission are described by their own set of equations: continuous and 
discrete, respectively. We choose different parameter values for these equa-
tions to determine if the population dynamics of ticks will tend to chaos. Our 
model is not intended to be a detailed description of the relationship between 
hosts and ticks, but rather an attempt to expand on what has already been 
modeled by Busenberg and Cooke [1993]. 
The following sections in this study describe the model equations and 
numerical results. The model equations section describes the modified model 
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and the method used to simulate the problem. The part. on numerical results 
shows an analysis of the graphs acquired by implementing the model. 
2 Model Equations 
We start with six basic assumptions. First, the host groups demography 
is insignificant and its population size is constant. Second, the probability 
of transmission from tick to host is equal to that from host to tick, given 
contact. Third, there is a probability that imniigrant ticks are infected or 
susceptible. The probability of susceptibility, F, is a relatively arbitrary 
value based loosely on the dynamics from simulations. Fourth, ( includes all 
possible causes of death in ticks. Fifth, recovered hosts remain susceptible. 
Sixth, th~ immigration rate (A) is constant in this model. 
To study the spread of R. rickettsii, it is necesary to understand the 
groups involved. First the ticks are separated into two classes, susceptible 
and infected. Second, the infection is spread through hosts, which are also 
divided into susceptible and infected classes: dlnfdt, dSnfdt, dlh/dt, dShfdt 
are the rates of change in the number of infected and susceptible ticks ( n) 
and hosts (h), respectively, over time. With these criteria, we formulate a 
model that more accurately describes the relationship between the host and 
the tick than the one presented by Busenberg and Cooke. 
Ih/dt 
dSh/dt 
dfn/dt 
dSn/dt -
k 
L 
LShln- w Ih 
-LShln + Wh 
(1 - F)A + kSnlh- "Yin 
FA- kSnh- (Sn 
pCn/Nh 
pCh/Nn. 
The susceptible ticks which get infected will move into the infected tick 
group at a rate of K Snlh, where K is the horizontal transmission factor. 
Snln represents a susceptible tick coming into contact with an infected host. 
This horizontal factor represents the probability per contact per individual, 
that is, the probability that the infection will be spread from one tick to 
another tick of the same generation. The term K Snh is added into the same 
equation for the infected ticks because the newly infected ticks are entering 
4 
the group, while it is subtracted from the equation for the susceptible ticks 
because it represents the ticks which are leaving the group due to infection. 
Ticks that die are also taken into account. The term rSn is subtracted 
from the differential equation for susceptible ticks, and rln is subtracted from 
the differential equation for infected ticks. 
The immigration of ticks into the tick community is represented by the 
symbol A. The probability that the incoming ticks will be infected is (1- F), 
so (1- F) is added to the equation for infected ticks. The probability that 
the incoming ticks are not infected is F, and F is added to the equation for 
susceptible ticks. 
Similarly, susceptible hosts are transferred into the infected host group 
at the ra:te of LShln, where Shh represents a susceptible host coming into 
contact with an infected tick, and L is the horizontal transmission factor. 
The recovery rate for the host is W h, which is added to the equation for 
susceptible hosts and subtracted from the equation for infected hosts. Since 
the host is immortal from the perspective of the tick, the number of hosts, 
Nh = h + Sh , is a constant. 
Vertical transmission is represented by the difference equations: 
IN(N) 
Since the differential set of equations only deals with the horizontal trans-
mission and not with the vertical transmission of the disease, the values of 
infected and susceptible ticks in a generation, In(n) and Sn(n), respectively, 
depend on the number of both groups from the previous generation. The 
life span of a tick is between 2 to 3 years. In the model we normalize this 
period to one unit of time, that is, each generation lives one unit of time. 
Ticks take a certain length of time to mature, after which they are able to 
lay eggs; m 1 and m 2 are the lower and upper boundaries, respectively, of the 
time interval in which a female tick can lay eggs. The interval m 1 - ~ is 
called the maturation window. Vertical transmission occurs when the female 
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tick passes the infection to her offspring. Therefore, to measure the vertical 
transmission would mean to take the integral from m 1 to fn2. Thus, we have 
the integral taken from m1 + n- 1 to 1112 + n - 1, where n- 1 is the end of 
the previous generation. 
In the difference equation for the infected tick population ( 1 - p) / ( m 2 -
m 1) represents the probability that the new generation is infected. The term 
bt ( t) I n- 1 ( t) represents the number of infected born from previous infected 
generations. The second term, [1- In-1(t)- Sn-l(t)] is the logistic control 
on the oviposition, or the laying of the eggs. 
In the difference equation for the susceptible ticks, the first term inside the 
integral, [bs(t)Sn_ 1(t)+pbi(t)In-1(t)], represents the births for the susceptible 
ticks of the previous generation and the probability of susceptible births from 
the previous infected generation. 
The second term inside the integral is the logistic control on the ovipo-
sition. The term outside the integral shows that there is no change in the 
spread of the infected from the previous generation during the maturation 
window. 
In this model, the maturation window has been modified. It is as-
sumed that all female adult ticks lay their eggs simultaneously, that is, 
m 1 ---+ m2 = m. By applying the fundamental theorem of calculus to the 
difference equations, this new set of difference equations is obtained: 
[(1- p)bi(M + N- l)IN-l(M + N- 1] 
[1- IN-l(M + N- 1)- SN-l(M + N -1)] 
[bs(M + N -1)SM+N-1 + pb1(M + N- 1)IN-I(M + N- 1)] 
[1 - IN-l (M + N- 1)- SN-l (M + N- 1)]. 
Using the difference and differential sets of equations, two Matlab pro-
grams were developed and run on SunSparc4 and SunSparc5 for various val-
ues of m, bJ, and bs. The first program, "driver" (see Appendix 1) depends 
on the second, "difchaos" (see Appendix 2). We assign arbitrary initial condi-
tions to the four differential equations. Then we solve them for h, In, Sh, Sn. 
We graph these solutions over a time interval. At the end of this simulation, 
we obtain values for these variables, taking into consideration only In and 
Sn because they refer to the tick population. We ignore the variables Sh and 
Ih because they deal with the hosts, and relative to the lifespan of the ticks, 
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the hosts have a much longer life span and can be assumed to live forever. 
The ODEs are solved for the time interval nand n + m, where n + m will 
provide the population size at time n + m, when female ticks lay eggs. These 
are plugged into the difference equations to obtain the population sizes of 
In, Sn, h, Sh at the beginning of the next generation. The ODEs are solved 
between n and n + 1 and the values at n+ 1 are plotted. Then the process is 
repeated for the new initial values obtained from the difference equations. 
3 Numerical Results 
Using the computer simulations, we obtained several graphs which illustrate 
the chaotic behavior of our model. In Figures 1 and 2 we plot In versus 
Sn for n = 101 : 1000 (i.e., generation numbers n ranging between 101 and 
1000) with the constant parameter values bs = bS = 3.6, b1 = bi = 4.0, 
p = 0.01, L = 0.5, w = w = 0.5, A = A = 0.4, 'Y = G = 0.3, K = 0.4, 
F = 0.35 and initial conditions: I(1) = 0.3, S(1) = 0.6. As m was varied 
(m = 0.02 for Fig. 1, and m = 0.5 for Fig. 2), we observed that the shape of 
the attractor also changed. This result indicates that m plays an important 
role in determining the dynamics of the systems. 
In Figures 3 and 4, we tried to identify the transient and true attractors 
for m = 0.05, bS = 4.0, bl = 3.6 (all other constant parameter values were 
kept). In Figure 3 we plotted In versus Sn for n = 101 : 1000. As expected, 
we found points that more or less seemed evenly distributed. In Figure 4, 
we plotted In versus Sn for n = 101 : 100,000. We obtained a more or less 
evenly distributed region of points which intuitively indicated the existence 
of only one true at tractor. 
In Figures 5 and 6 we illustrated the dynamic behavior by plotting the last 
hundred points for infected and susceptible tick populations out of Fig. 3 and 
Fig. 4 versus time; at m for each generation n, we obtain points with respect 
to time which describe the size of the infected and susceptible populations 
of the next generation. These points are connected so as to provide a better 
visual idea of the chaotic behavior of the system. 
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4 Conclusion 
Based on the characteristics of chaos given by Kaplan and Glass (Under-
standing Nonlinear Dynamics 1995), we conclude by saying that our model 
seems to have chaotic behavior. It is important to note that our modified 
model has an attractor that seems to differ from that in the BC model. From 
a biological point of view because there is no pattern to follow in order to 
reach specific conclusions. More mathematical analysis is needed to see the 
biological implications of the systems behavior. Due to time constraints, this 
was not possible. 
Suggestions for Future Study 
In order to form a better model, revising the model is suggested so that 
a broader maturation window can be included in it. More simulations would 
enhance the hypothesis and help characterize chaos in a more precise way. 
Another way to describe the boundaries of chaos more clearly is to find the 
bifurcation diagram for this model. Unfortunately, the end of the summer 
also brought dissolution of our research group. 
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Figure 1 
This is the graph for the infected ticks versus susceptible ticks for 1000 
generations. The maturation window is 0.02, the birthrate of susceptible 
ticks is 3.6, and the infected birthrate is 4.0. 
Figure 2 
In this graph, all parameters were kep the same from the previous figure 
except that the maturation window is 0.5, which is of greater value. This 
graph also shows the simulation over 1000 generations. 
Figure 3 
In this figure, the value for the maturation window is 0.05, but the infected 
and susceptible birthrates have been switched. This graph also shows the 
simulation over 1000 generations. 
Figure 4 
This graph shows the simulation of infected versus susceptible ticks. The 
maturation window is 0.05, the infected birthrate is 3.6 and the susceptible 
birthrate is 4.0. 
Figure 5 
Last 100 generations of population of infected ticks with respect to the 
generations, graphing only every 15th generation of Fig. 3. 
Figure 6 
The last 100 generations of the population of susceptible ticks with respect 
to the generations, graphing only every 15th generation of Fig. 3. 
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Computer Programs 
The following section contains the computer programs in Matlab used to 
generate the simulations. 
function xdot = difchaos(t 1 x) 
L=.S; 
Psi=.S; 
Lam=0.4; 
G=0.3; 
.K=. 4; 
IF=O. 35; 
% x(l)=Id(t) 1 x(2)=Sd(t) 1 x(3)=In(t) 1 x(4)=Sn(t) 
%system of ODE's 
~dot(l) = L*x(2) .*x(3) - Psi*x(l); 
xdot(2) = -L*x(2) .*x(3) + Psi*x(l); 
iKdot(3) = K*x(4) .*x(l) - G*x(3) + (1-F)*Lam; 
xdot(4) = -K*x(4) .*x(l) - G*x(4) + F*Lam; 
function y =driver(RR) 
%parameter values will change at each simulation 
bi=3.6; bs=4.0; p=0.01; 
%initial 
i=1; 
its=15; 
m=.S; 
x0=[.2 .8 
time and number of ticks and dogs 
%we save only every "its"th point 
%maturation point, time when ticks start laying eggs 
.3 .6]'; %initial values Id, Sd, In, and Sn for generation 1 
%initializes a matrix of zeroes where the solutions y will be saved 
y=zeros(round((RR-100)/its),2}; 
%finds the solutions for every generation, from 1 to RR 
for n=1:RR 
%finds solutions to the ODE system from the beginning of the generation 
%up to time n+m 
[t2,x2]=ode45('difchaos' ,n,n+m,xO}; 
%finds the last component of the ODE solution x2 
d2=length(x2(:,1)); 
X0 =X2 ( d2 1 ! ) 1 j 
%finds solutions to the ODE system from the beginning of the generation 
%up to time n+1 
[t1,x1]=ode45('difchaos' ,n+m,n+l,xO}; 
%finds the last component of the ODE solution xl 
dl=length(x1(:,1)); 
%x(3,d} = # infected ticks at end of the generation 
%x(4,d) = # susceptible ticks at end of the generation 
%set of difference equations 
In=(1-p)*bi*x2(d2,3}*(1-x2(d2,3}-x2(d2,4)}; 
Sn={bs*x2(d2,4)+p*bi*x2(d2,3)}*(1-x2(d2,3)-x2(d2,4}}; 
%new initial points for the next generation 
x0=[x1(d1,1} x1(d1,2) In Sn] '; 
%saves only every "its"th point 
if ( (rem(n,its} == 0} & (n > 100} 
end; 
end; 
y(i,1:2}=[x1{d1,4) x1(d1,3}]; 
i=i+l; 
